<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Dis Model Mech</journal-id>
<journal-id journal-id-type="iso-abbrev">Dis Model Mech</journal-id>
<journal-id journal-id-type="publisher-id">DMM</journal-id>
<journal-id journal-id-type="hwp">dmm</journal-id>
<journal-title-group>
<journal-title>Disease Models &amp; Mechanisms</journal-title>
</journal-title-group>
<issn pub-type="ppub">1754-8403</issn>
<issn pub-type="epub">1754-8411</issn>
<publisher>
<publisher-name>The Company of Biologists Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30578246</article-id>
<article-id pub-id-type="pmc">6307911</article-id>
<article-id pub-id-type="doi">10.1242/dmm.035931</article-id>
<article-id pub-id-type="publisher-id">DMM035931</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-7399-4304</contrib-id>
<name>
<surname>Nickolls</surname>
<given-names>Alec R.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="aff" rid="af2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-5930-2324</contrib-id>
<name>
<surname>Bönnemann</surname>
<given-names>Carsten G.</given-names>
</name>
<xref ref-type="aff" rid="af1">1</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="af1"><label>1</label><institution>National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution>, <addr-line>Bethesda, MD 20892</addr-line>, <country>USA</country></aff>
<aff id="af2"><label>2</label><addr-line>Department of Neuroscience</addr-line>, <institution>Brown University</institution>, <addr-line>Providence, RI 02912</addr-line>, <country>USA</country></aff>
<author-notes>
<corresp id="cor1"><label>*</label>Author for correspondence (<email>carsten.bonnemann@nih.gov</email>)</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>12</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>19</day>
<month>12</month>
<year>2018</year>
</pub-date>
<!-- PMC Release delay is 0 months and 0 days and was based on the epub date downloaded from Highwire. -->
<volume>11</volume>
<issue>12</issue>
<elocation-id>dmm035931</elocation-id>
<permissions>
<copyright-statement>© 2018. Published by The Company of Biologists Ltd</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="open-access">
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref>
<license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<uri xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</uri>), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="dmm-11-035931.pdf"></self-uri>
<abstract>
<title>ABSTRACT</title>
<p>Dystroglycan is a cell membrane protein that binds to the extracellular matrix in a variety of mammalian tissues. The α-subunit of dystroglycan (αDG) is heavily glycosylated, including a special O-mannosyl glycoepitope, relying upon this unique glycosylation to bind its matrix ligands. A distinct group of muscular dystrophies results from specific hypoglycosylation of αDG, and they are frequently associated with central nervous system involvement, ranging from profound brain malformation to intellectual disability without evident morphological defects. There is an expanding literature addressing the function of αDG in the nervous system, with recent reports demonstrating important roles in brain development and in the maintenance of neuronal synapses. Much of these data are derived from an increasingly rich array of experimental animal models. This Review aims to synthesize the information from such diverse models, formulating an up-to-date understanding about the various functions of αDG in neurons and glia of the central and peripheral nervous systems. Where possible, we integrate these data with our knowledge of the human disorders to promote translation from basic mechanistic findings to clinical therapies that take the neural phenotypes into account.</p>
</abstract>
<abstract abstract-type="precis">
<p><bold>Summary:</bold> Dystroglycan is a ubiquitous matrix receptor linked to brain and muscle disease. Unraveling the functions of this protein will inform basic and translational research on neural development and muscular dystrophies.</p>
</abstract>
<kwd-group>
<title>KEY WORDS</title>
<kwd>Muscular dystrophy</kwd>
<kwd>Brain development</kwd>
<kwd>Dystroglycan</kwd>
<kwd>Animal models</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution>National Institute of Neurological Disorders and Stroke</institution>
<institution-id>http://dx.doi.org/10.13039/100000065</institution-id>
</institution-wrap>
</funding-source>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Dystroglycan is a receptor of extracellular matrix (ECM) proteins in many developing and adult mammalian tissues (<xref ref-type="bibr" rid="DMM035931C84">Ibraghimov-Beskrovnaya et al., 1993</xref>; <xref ref-type="bibr" rid="DMM035931C16">Blaeser et al., 2018</xref>), and is composed of two protein subunits translated from a single mRNA transcript of the <italic>DAG1</italic> gene (<xref ref-type="bibr" rid="DMM035931C83">Ibraghimov-Beskrovnaya et al., 1992</xref>). The α-subunit, designated as α-dystroglycan (αDG), resides at the outer surface of the plasma membrane, where it shares a tight noncovalent bond with the membrane-spanning β-subunit (βDG) (<xref ref-type="bibr" rid="DMM035931C76">Holt et al., 2000</xref>; <xref ref-type="bibr" rid="DMM035931C5">Akhavan et al., 2008</xref>). The intracellular domain of βDG interacts with cytosolic proteins, most notably those of the dystrophin family (<xref ref-type="bibr" rid="DMM035931C213">Xin et al., 2000</xref>; <xref ref-type="bibr" rid="DMM035931C147">Palmieri et al., 2017</xref>). Together, αDG, βDG and dystrophin represent the core functional unit of the dystrophin-glycoprotein complex, physically linking ECM and cytoskeletal elements (see <xref ref-type="boxed-text" rid="DMM035931B1">Box 1</xref> for an overview of dystroglycan structure and interactions).
<boxed-text id="DMM035931B1" orientation="portrait" position="float"><caption><title>Box 1. Structure and interactions of dystroglycan</title></caption><p>The <italic>DAG1</italic> gene is transcribed to an mRNA containing a single open reading frame encoding both αDG and βDG (<xref ref-type="bibr" rid="DMM035931C84">Ibraghimov-Beskrovnaya et al., 1993</xref>). The <italic>DAG1</italic> mRNA transcript is translated to a precursor polypeptide that is subsequently cleaved by an unidentified enzyme to generate the αDG and βDG proteins (<xref ref-type="bibr" rid="DMM035931C76">Holt et al., 2000</xref>). αDG consists of a central mucin-like domain flanked by two globular domains (<xref ref-type="bibr" rid="DMM035931C22">Brancaccio et al., 1995</xref>). The C-terminal globular domain is non-covalently linked to βDG at the cell surface, with βDG containing a transmembrane domain and a cytoplasmic C-terminus (see schematic below).</p><p><inline-graphic xlink:href="dmm-11-035931-i6.jpg"></inline-graphic></p><p>aa, amino acid.</p><p>The N-terminal globular domain of αDG is critical for enzymatic recognition and post-translational processing of the protein in the endoplasmic reticulum and Golgi apparatus (<xref ref-type="bibr" rid="DMM035931C92">Kanagawa et al., 2004</xref>). However, the N-terminus is ultimately removed in the Golgi apparatus, and this region is not directly involved in αDG function (<xref ref-type="bibr" rid="DMM035931C23">Brancaccio et al., 1997</xref>). The central mucin-like domain of αDG receives abundant post-translational modification in the form of glycosylation, which is required for interaction between αDG and its ligands.</p><p>αDG binds to extracellular proteins, including laminins, agrin and perlecan, in the muscle and brain microenvironment (<xref ref-type="bibr" rid="DMM035931C83">Ibraghimov-Beskrovnaya et al., 1992</xref>; <xref ref-type="bibr" rid="DMM035931C21">Bowe et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C28">Campanelli et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C51">Gee et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C191">Sugiyama et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C152">Peng et al., 1998</xref>). Similarly, αDG interacts with slit proteins in the spinal cord, neurexin proteins in the brain and pikachurin in the retina (<xref ref-type="bibr" rid="DMM035931C190">Sugita et al., 2001</xref>; <xref ref-type="bibr" rid="DMM035931C174">Sato et al., 2008</xref>; <xref ref-type="bibr" rid="DMM035931C212">Wright et al., 2012</xref>). These interactions have various structural and functional consequences in their respective tissues, as discussed in this Review. Interestingly, brain αDG has reduced glycosylation and ligand binding affinity compared with that of muscle αDG, but the physiological implication of these differences is unknown (<xref ref-type="bibr" rid="DMM035931C186">Smalheiser and Kim, 1995</xref>; <xref ref-type="bibr" rid="DMM035931C55">Gesemann et al., 1998</xref>; <xref ref-type="bibr" rid="DMM035931C104">Leschziner et al., 2000</xref>).</p></boxed-text></p>
<p>The expression of this protein complex is widespread; αDG is found in cells of the skeletal muscle, nervous system, digestive tract, kidney, skin and reproductive organs (<xref ref-type="bibr" rid="DMM035931C44">Durbeej et al., 1998</xref>). Many functions have been ascribed to αDG, depending on developmental and cell-specific contexts. αDG participates in basement membrane formation (see <xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref> for a glossary of terms) and in signal transduction from the ECM (<xref ref-type="bibr" rid="DMM035931C62">Gracida-Jiménez et al., 2017</xref>). Further, through physical anchorage with the surrounding matrix, αDG protects muscle cell membranes against contraction-induced damage (<xref ref-type="bibr" rid="DMM035931C70">Han et al., 2009</xref>).
<boxed-text id="DMM035931B2" orientation="portrait" position="float"><caption><title>Box 2. Glossary</title></caption><p><bold>Agrin:</bold> a proteoglycan secreted by nerve terminals that binds to MuSK and αDG on the postsynaptic muscle membrane. Agrin is the main instructive secreted signal for neuromuscular junction formation.</p><p><bold>Basement membrane:</bold> compact sheets of polymerized matrix proteins, generally composed of laminin, collagen, perlecan and nidogen proteins. Basement membranes can be divided into three layers based on electron microscopy: (1) an electron-sparse ‘lamina lucida’ at the cell surface made of the cell-binding long arm of laminin, (2) an overlying ‘lamina densa’ of type IV collagen, perlecan, nidogen and the crosslinking shorter arms of laminin, (3) and beyond this a ‘lamina reticularis’ of fibrillar collagens. This molecular lattice forms the periphery of many organs, serves to anchor individual cells and provides a framework for tissue structure in all metazoan organisms.</p><p><bold>Cobblestone lissencephaly:</bold> a developmental condition characterized by an unusually smooth brain surface with abnormally formed gyri resembling a ‘cobbled’ exterior, also referred to as lissencephaly type II. It results from over-migration of neurons into the subarachnoid space, resulting in the finely cobbled smooth surface with underlying dense folding or gyri resembling polymicrogyria.</p><p><bold>Cre-driver line:</bold> a mouse strain genetically engineered with a Cre recombinase gene driven by a promoter of choice. When crossed with a strain harboring strategically placed loxP sites in a gene of interest (floxed exons), this will result in temporal and cell-type-selective gene knockout (termed the Cre/<italic>lox</italic> system).</p><p><bold><italic>DAG1</italic>:</bold> the gene encoding αDG and βDG, which are transcribed and translated as one and cleaved post-translationally.</p><p><bold>Electroretinogram (ERG):</bold> an electrode measurement of signaling between photoreceptors and their downstream bipolar and ganglion cells in the retina. On the ERG trace, the first deflection is the a-wave, representing photoreceptor activity, and the second deflection is the b-wave, mediated by ganglion and bipolar cells.</p><p><bold>Embryoid body:</bold> a culture of embryonic stem cells in spherical aggregates that differentiate an inner epiblast-like core and an extraembryonic endoderm-like periphery. Between these two cell layers forms a basement membrane reminiscent of that found between the epiblast and primitive endoderm of the pre-gastrulation mammalian embryo.</p><p><bold>Glycosylation:</bold> the post-translational process of adding carbohydrate chains, or glycans, to proteins by glycosyltransferase enzymes of the endoplasmic reticulum and Golgi apparatus. These sugars often mediate protein folding or protein-protein interactions. A form of glycosylation on αDG that can be disturbed in the α-dystroglycanopathies is referred to as O-mannosylation, indicating the molecular bond and first sugar added.</p><p><bold>Hydrocephaly:</bold> a condition of increased cerebrospinal fluid volume in the brain that leads to expansion of the ventricles and often the skull.</p><p><bold>Hypoglycosylation:</bold> a reduced number of glycans on a glycosylated protein. This is detected by a reduction in the protein's molecular mass and, in the case of αDG, it is concomitant with a reduced ability to bind extracellular ligands such as laminin.</p><p><bold>Laminins:</bold> massive cross-shaped heterotrimeric extracellular matrix proteins that bind to cell surface αDG and integrin. Along with type IV collagen, laminins are major constituents of basement membranes. They are typically composed of one heavy α chain and β and γ light chains. Their nomenclature follows the number for the α, β and γ chain, so that a heterotrimer composed of α2, β1 and γ1 would be designated as laminin 211 or lm211.</p><p><bold><italic>Large</italic>:</bold> the gene encoding like-acetylglucosaminyltransferase (also known as Large), the final bifunctional glycosyltransferase directly responsible for synthesizing matriglycans on αDG.</p><p><bold>LG domains:</bold> protein structures of the laminin globular domain family. They are commonly found in extracellular proteins and are involved in protein-protein interaction.</p><p><bold>Matriglycan:</bold> a unique glycan consisting of repeating disaccharide units (xylose and glucuronic acid) that binds to LG domains found in laminin and other proteins. It is the final result of Large glycosyltransferase activity.</p><p><bold>MuSK:</bold> a receptor tyrosine kinase found in the muscle cell membrane that mediates neuromuscular junction formation in response to agrin binding.</p><p><bold>Neural dysplasia:</bold> abnormal positioning of neuronal and glial cells in the nervous system as a result of disturbed development, either within or beyond their normal tissue borders, causing ectopic localization of mixed cellular populations (heterotopia).</p><p><bold>Neuromuscular junction (NMJ):</bold> the synapse formed between the motor neuron and the muscle fiber, allowing motor impulses to induce muscle contraction.</p><p><bold>Node of Ranvier:</bold> a section of neural axon that lacks a myelin sheath to allow ion permeability and action potential propagation. These gaps occur at regular intervals along the axon of all myelinated neurons.</p><p><bold>Pia mater:</bold> the innermost layer of meningeal membranes lining the brain. It is composed of a heterogeneous population of cells including fibroblasts that secrete laminin and other matrix proteins to form the pial basement membrane at the surface of the brain.</p><p><bold>Pyridostigmine:</bold> an acetylcholinesterase inhibitor used to enhance nerve-muscle signaling and reduce muscle weakness.</p><p><bold>Reelin:</bold> a signaling molecule secreted during development by Cajal–Retzius cells in the hippocampus and neocortex. Reelin is critical for proper neuronal migration and function in both the developing and adult brain.</p></boxed-text></p>
<p>Aside from binding endogenous extracellular ligands, αDG is a receptor for <italic>Mycobacterium leprae</italic> – the organism responsible for leprosy – and for the Lassa hemorrhagic fever virus and the lymphocytic choriomeningitis virus (<xref ref-type="bibr" rid="DMM035931C29">Cao et al., 1998</xref>; <xref ref-type="bibr" rid="DMM035931C162">Rambukkana et al., 1998</xref>). The interaction between αDG and many of its extracellular binding partners is mediated by glycosylation (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>). Loss-of-function mutations in certain glycosyltransferase enzymes, discussed in more detail below, cause αDG hypoglycosylation (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>), which diminishes the binding affinity between αDG and its extracellular ligands (<xref ref-type="fig" rid="DMM035931F1">Fig. 1</xref>A,B).
<fig id="DMM035931F1" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p><bold>Molecular pathogenesis of α-dystroglycanopathies.</bold> (A) Schematic of dystroglycan protein interactions based on biochemical and functional evidence. A truncated form of αDG is most likely on display at the membrane surface, as the N-terminal region is cleaved during Golgi processing (<xref ref-type="bibr" rid="DMM035931C92">Kanagawa et al., 2004</xref>). Matriglycan chains on the central mucin domain of αDG bind directly to laminin in the overlying basement membrane, while βDG is linked to the intracellular actin cytoskeleton through dystrophin. (B) Mutations in glycosyltransferase genes responsible for matriglycan construction cause a hypoglycosylation of αDG, resulting in loss of αDG-laminin binding and disruption of cell-matrix interaction. nNOS, neuronal nitric oxide synthase.</p></caption><graphic xlink:href="dmm-11-035931-g1"></graphic></fig></p>
<p>In humans, the hypoglycosylation of αDG is characterized by progressive muscular dystrophy frequently associated with brain malformation and intellectual disability – a spectrum of recessive genetic disorders referred to as α-dystroglycanopathies. Researchers frequently use animal models of α-dystroglycanopathies to study the dysfunction of αDG in the brain, eye and peripheral nerve, because these are the least accessible components of the human pathology. Here, we summarize findings from these animal models and derive key inferences regarding the functions of αDG in the nervous system, with particular focus on their relevance to the human disorders.</p>
</sec>
<sec id="s2">
<title>Molecular pathogenesis of α-dystroglycanopathies</title>
<p>αDG is so heavily glycosylated that carbohydrates constitute over half of the glycoprotein's mass. Of these carbohydrate structures, matriglycan (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) is directly responsible for the binding of αDG to its ECM ligands. It is comprised of a massive repeating disaccharide (-3Xylα1-3GlcAβ1-) that tightly binds LG domains (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) in the laminin, agrin (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>), perlecan, slit, neurexin and pikachurin extracellular proteins (<xref ref-type="bibr" rid="DMM035931C24">Briggs et al., 2016</xref>). Matriglycans are synthesized by the enzyme Large and are bound to αDG through a tandem ribitol phosphate and a core O-linked trisaccharide (GalNAcβ1-3GlcNAcβ1-4Man-) (<xref ref-type="bibr" rid="DMM035931C94">Kanagawa et al., 2016</xref>). The maximum quantity and repeat length of matriglycan molecules on αDG is not known.</p>
<p>To date, 16 genes have been identified as definitive contributors to the construction of functional matriglycans on αDG (<xref ref-type="table" rid="DMM035931TB1">Table 1</xref>, <xref ref-type="fig" rid="DMM035931F2">Fig. 2</xref>). A 17th gene, <italic>POMGNT1</italic>, is not directly involved in matriglycan synthesis but is thought to regulate its installation on αDG (<xref ref-type="bibr" rid="DMM035931C221">Yoshida-Moriguchi et al., 2010</xref>). Loss of function in any of these genes compromises matriglycan structure and impairs αDG ligand-binding affinity, leading to a clinical condition called secondary α-dystroglycanopathy. In such cases, αDG maintains normal tissue expression and localization, but is hypoglycosylated (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>).
<table-wrap id="DMM035931TB1" orientation="portrait" position="float"><label>Table 1.</label><caption><p><bold>Genes involved in secondary α-dystroglycanopathies</bold></p></caption><graphic xlink:href="dmm-11-035931-i1"></graphic></table-wrap>
<fig id="DMM035931F2" orientation="portrait" position="float"><label>Fig. 2.</label><caption><p><bold>Glycosylation of α-dystroglycan.</bold> A simplified representation of the post-translational modifications on αDG, with arrows indicating each enzyme's respective glycan additions. POMT1/POMT2 catalyze the first step of glycosylation by adding an O-linked mannose to αDG in a process called O-mannosylation. The LARGE glycosyltransferase catalyzes the final step for the installation of the matriglycan, a repeating disaccharide of variable length that directly binds extracellular laminin. Other enzymes have been shown to be indirectly involved in αDG glycosylation through the synthesis of cytidine diphosphate ribitol (CDP-Rbo) and dolichol phosphate mannose (Dol-P-Man). Pathogenic mutations in each enzyme listed here are linked to the wide clinical spectrum of the α-dystroglycanopathies. For a detailed review, see <xref ref-type="bibr" rid="DMM035931C227">Kanagawa and Toda, 2017</xref>.</p></caption><graphic xlink:href="dmm-11-035931-g2"></graphic></fig></p>
<p>Rare mutations in <italic>DAG1</italic> (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>), the gene encoding αDG and βDG, have also been reported to interfere with the process of matriglycan addition, either through inhibiting the extension of matriglycan (<xref ref-type="bibr" rid="DMM035931C71">Hara et al., 2011</xref>) or by perturbing the maturation and trafficking of αDG (<xref ref-type="bibr" rid="DMM035931C52">Geis et al., 2013</xref>; <xref ref-type="bibr" rid="DMM035931C184">Signorino et al., 2018</xref>). Clinical conditions arising from mutations in DAG1 itself are referred to as primary α-dystroglycanopathies. Frameshift mutations in <italic>DAG1</italic> can completely abrogate αDG and βDG, resulting in particularly severe clinical manifestations (<xref ref-type="bibr" rid="DMM035931C164">Riemersma et al., 2015</xref>). Often, but not always, the degree of αDG hypoglycosylation correlates with disease severity (<xref ref-type="bibr" rid="DMM035931C90">Jimenez-Mallebrera et al., 2009</xref>; <xref ref-type="bibr" rid="DMM035931C6">Alhamidi et al., 2017</xref>).</p>
<p>New genes continue to be implicated in α-dystroglycanopathies and further expand our view of αDG biosynthesis. Mutations in the Golgi membrane trafficking proteins TRAPPC11 and GOSR2 (<xref ref-type="table" rid="DMM035931TB1">Table 1</xref>) were recently reported to cause hypoglycosylation of αDG linked to muscular dystrophy, epilepsy and brain abnormalities (<xref ref-type="bibr" rid="DMM035931C100">Larson et al., 2018</xref>). Given the more general nature of an ER-to-Golgi transport defect, it is likely that hypoglycosylated αDG is not the only disease mechanism for these two genes. Because many patients still lack a molecular diagnosis (<xref ref-type="bibr" rid="DMM035931C58">Godfrey et al., 2007</xref>; <xref ref-type="bibr" rid="DMM035931C129">Mercuri et al., 2009</xref>; <xref ref-type="bibr" rid="DMM035931C64">Graziano et al., 2015</xref>), there are probably additional genes involved in α-dystroglycanopathies waiting to be identified.</p>
</sec>
<sec id="s3">
<title>Neurological phenotypes in α-dystroglycanopathies</title>
<p>α-Dystroglycanopathies encompass a wide spectrum of disease severities that include disrupted nervous system development and progressive muscular dystrophy (see <xref ref-type="boxed-text" rid="DMM035931B3">Box 3</xref> for details on the muscular phenotypes of α-dystroglycanopathies). The most severely affected patients present with profound brain malformation and ultimately do not survive infancy – a phenotype referred to as Walker–Warburg syndrome (<xref ref-type="bibr" rid="DMM035931C39">Cormand et al., 2001</xref>). Affected individuals can display profound cognitive deficits, hydrocephaly (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>), and brain and retinal dysplasia, some of which may be observed by ultrasound during gestation (<xref ref-type="bibr" rid="DMM035931C205">Vohra et al., 1993</xref>; <xref ref-type="bibr" rid="DMM035931C197">Trkova et al., 2015</xref>). Other syndromes recognized in the spectrum of α-dystroglycanopathy include (in order of decreasing severity) muscle-eye-brain (MEB) disease, Fukuyama-type congenital muscular dystrophy, and several forms of congenital and limb-girdle muscular dystrophies (reviewed by <xref ref-type="bibr" rid="DMM035931C59">Godfrey et al., 2011</xref>).
<boxed-text id="DMM035931B3" orientation="portrait" position="float"><caption><title>Box 3. Muscular phenotypes of α-dystroglycanopathies</title></caption><p>Muscular dystrophy is a central feature in α-dystroglycanopathies. In humans, muscular dystrophies are a large group of genetically mediated disorders of muscle, histologically characterized by muscle degeneration, attempted regeneration, and subsequent fibrosis and fatty replacement. Clinically, muscular dystrophies are extremely diverse but have progressive muscle weakness as a common feature. If the onset is pre-natal or around birth, they are referred to as congenital muscular dystrophies. Patients with severe α-dystroglycanopathy die in the first years of life, but mild forms can still be fatal due to intractable epilepsy or respiratory failure (<xref ref-type="bibr" rid="DMM035931C130">Messina et al., 2009</xref>; <xref ref-type="bibr" rid="DMM035931C43">Di Rosa et al., 2011</xref>; <xref ref-type="bibr" rid="DMM035931C148">Pane et al., 2012</xref>).</p><p>Mice with global deletion of matriglycan-forming glycosyltransferases develop hallmarks of α-dystroglycanopathies, including muscular dystrophy and brain malformation. In addition to moderate cortical dysplasia, the <italic>Large</italic><sup>myd</sup> mouse shows an adult-onset progressive muscle wasting phenotype accompanied by stiffening limbs (<xref ref-type="bibr" rid="DMM035931C96">Kelly et al., 1994</xref>). In contrast, <italic>Fkrp</italic> mutant mice (L276I/P448L and L276I/E310del) show a milder form of muscular dystrophy with no overt brain abnormalities (<xref ref-type="bibr" rid="DMM035931C15">Blaeser et al., 2013</xref>). Interestingly, Cre-mediated deletion of <italic>Dag1</italic> in mature skeletal muscle causes only a mild dystrophy, as regeneration is aided by αDG-expressing muscle progenitor cells (<xref ref-type="bibr" rid="DMM035931C35">Cohn et al., 2002</xref>). Thus, in addition to its various roles in the nervous system discussed in this Review, αDG critically maintains differentiated and regenerating muscle fibers.</p></boxed-text></p>
<p>A common feature of severe α-dystroglycanopathies is cobblestone lissencephaly (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) and an array of neurological defects (<xref ref-type="fig" rid="DMM035931F3">Fig. 3</xref>A). Light and electron microscopy of postmortem tissue establish a general theme of aberrant cell migration underlying such nervous system dysplasia (<xref ref-type="bibr" rid="DMM035931C137">Nakano et al., 1996</xref>). Examination of the cerebral cortex, cerebellum, retina, brainstem and spinal cord shows gross morphological abnormalities due to displacement of neurons both within the tissue and beyond its normal borders (<xref ref-type="bibr" rid="DMM035931C216">Yamamoto et al., 1997</xref>, <xref ref-type="bibr" rid="DMM035931C217">2008</xref>). In some cases, there is evidence of atrophy in the spinal cord and retina (<xref ref-type="bibr" rid="DMM035931C128">Meilleur et al., 2014</xref>), sometimes accompanied by progressive dysfunction of ocular physiology (<xref ref-type="bibr" rid="DMM035931C173">Santavuori et al., 1989</xref>; <xref ref-type="bibr" rid="DMM035931C154">Pihko et al., 1995</xref>; <xref ref-type="bibr" rid="DMM035931C39">Cormand et al., 2001</xref>; <xref ref-type="bibr" rid="DMM035931C206">von Renesse et al., 2014</xref>).
<fig id="DMM035931F3" orientation="portrait" position="float"><label>Fig. 3.</label><caption><p><bold>Neural phenotypes in α-dystroglycanopathies.</bold> (A) Diagram of the nervous system regions primarily affected in α-dystroglycanopathies. Gross malformations are commonly reported in the brain and eyes and can include displaced neurons and glia (heterotopia), and abnormally small pons and cerebellum (pontocerebellar hypoplasia). These structural phenotypes are often accompanied by functional deficits in cognition and vision (myopia) (<xref ref-type="bibr" rid="DMM035931C173">Santavuori et al., 1989</xref>; <xref ref-type="bibr" rid="DMM035931C154">Pihko et al., 1995</xref>; <xref ref-type="bibr" rid="DMM035931C39">Cormand et al., 2001</xref>; <xref ref-type="bibr" rid="DMM035931C206">von Renesse et al., 2014</xref>). (B) Healthy brain development involves radial migration of newborn neurons (white arrow) into laminae of the cortical plate. Radial glia anchored to the pial basement membrane act as a guiding scaffold. Cortical dysplasia in α-dystroglycanopathy models is characterized by discontinuity of the pial basement membrane, disorganization of radial glial endfeet, abnormal migration of cells into the subarachnoid space and disrupted cortical lamination. CP, cortical plate; GL, glia limitans; IZ, intermediate zone; MZ, marginal zone; PM, pia mater; SAS, subarachnoid space; SP, subplate; VZ, ventricular zone.</p></caption><graphic xlink:href="dmm-11-035931-g3"></graphic></fig></p>
<p>Over two decades of accumulated research triangulates αDG dysfunction as a primary causative mechanism for this class of muscular dystrophies with central nervous system involvement. In mice, disruption of the genes involved in the synthesis of matriglycans on αDG, or in <italic>Dag1</italic> itself, results in animals that recapitulate the human condition in many respects (<xref ref-type="bibr" rid="DMM035931C131">Michele et al., 2002</xref>; <xref ref-type="bibr" rid="DMM035931C134">Moore et al., 2002</xref>). Despite our knowledge regarding the genetic etiology of α-dystroglycanopathies, the pathogenic events leading to such a heterogeneous spectrum of disease remain unclear.</p>
</sec>
<sec id="s4">
<title>Considerations for the use of α-dystroglycanopathy models</title>
<p>An increasingly rich assortment of model systems is currently available for investigating α-dystroglycanopathies. Interpreting the literature necessitates considering the strengths and weaknesses of each model, and selecting the best model requires factoring these caveats into the goals of future studies.</p>
<p>Traditionally, mice have been the preferred animal model for α-dystroglycanopathies. There are at least 41 distinct genetic mouse models: 15 that directly mutate or delete <italic>Dag1</italic> itself (<xref ref-type="table" rid="DMM035931TB2">Table 2</xref>), and 26 that model the hypoglycosylation of αDG through mutation or deletion of glycosyltransferase genes (<xref ref-type="table" rid="DMM035931TB3">Tables 3</xref> and <xref ref-type="table" rid="DMM035931TB4">4</xref>). Global deletion of <italic>Dag1</italic> or the glycosyltransferases <italic>Pomt1</italic>, <italic>Pomt2</italic>, <italic>Fktn</italic> or <italic>Fkrp</italic> is embryonic lethal in mice due to disruption of Reichert's membrane, a murine basement membrane barrier between embryonic and placental tissue (<xref ref-type="bibr" rid="DMM035931C211">Williamson et al., 1997</xref>; <xref ref-type="bibr" rid="DMM035931C209">Willer et al., 2004</xref>; <xref ref-type="bibr" rid="DMM035931C98">Kurahashi et al., 2005</xref>; <xref ref-type="bibr" rid="DMM035931C33">Chan et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C80">Hu et al., 2011a</xref>,<xref ref-type="bibr" rid="DMM035931C81">b</xref>). Defects in Reichert's membrane also occur upon knockout of glycosyltransferase enzymes involved in matriglycan synthesis (<xref ref-type="bibr" rid="DMM035931C209">Willer et al., 2004</xref>; <xref ref-type="bibr" rid="DMM035931C98">Kurahashi et al., 2005</xref>; <xref ref-type="bibr" rid="DMM035931C33">Chan et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C80">Hu et al., 2011a</xref>). This membrane is not present in human embryos, and thus these models are only practical for assessing the role of αDG in early murine development.
<table-wrap id="DMM035931TB2" orientation="portrait" position="float"><label>Table 2.</label><caption><p><bold>Dystroglycan-deficient mouse models</bold></p></caption><graphic xlink:href="dmm-11-035931-i2"></graphic></table-wrap>
<table-wrap id="DMM035931TB3" orientation="portrait" position="float"><label>Table 3.</label><caption><p><bold>Glycosyltransferase-deficient mouse models: <italic>Pomt1</italic>, <italic>Pomt2, Pomgnt1</italic>, <italic>Pomgnt2</italic>, <italic>Ispd</italic>, <italic>B4gat1</italic>, <italic>Large</italic></bold></p></caption><graphic xlink:href="dmm-11-035931-i3"></graphic></table-wrap>
<table-wrap id="DMM035931TB4" orientation="portrait" position="float"><label>Table 4.</label><caption><p><bold>Glycosyltransferase-deficient mouse models: <italic>Fktn</italic>, <italic>Fkrp</italic></bold></p></caption><graphic xlink:href="dmm-11-035931-i4"></graphic></table-wrap></p>
<p>Many Cre-driver mouse lines (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) are used for tissue-specific deletion of <italic>Dag1</italic>, allowing embryonic survival and therefore the study of phenotypes in older animals. Particularly useful have been the GFAP-Cre, NEX (also known as Neurod6)-Cre and Nes (also known as nestin)-Cre mice, which drive recombination in glia, neurons and neural stem cells, respectively. Crossing these lines with floxed <italic>Dag1</italic> mice is a common strategy for investigating dystroglycan's functional contributions in distinct cell types (<xref ref-type="bibr" rid="DMM035931C177">Satz et al., 2010</xref>). Neuron subtype-selective approaches are also possible – for example, Pcp2-Cre mice exhibit recombination primarily in cerebellar Purkinje neurons (<xref ref-type="bibr" rid="DMM035931C139">Nguyen et al., 2013</xref>).</p>
<p>A recent comparison of α-dystroglycanopathy mouse models demonstrated significant phenotypic differences depending on the Cre-driving promoter. Gene knockout driven by Nes-Cre showed a considerably milder effect compared with that driven by Emx1-Cre (<xref ref-type="bibr" rid="DMM035931C189">Sudo et al., 2018</xref>). Neural stem cells of the cerebral cortex express both Nes and Emx1, but Nes-Cre-driven knockout was inefficient in early stages of development (<xref ref-type="bibr" rid="DMM035931C112">Liang et al., 2012</xref>). Because the timing of αDG loss of function has important phenotypic consequences, Emx1-Cre mice might be a preferred system for investigating the functional contribution of αDG during fetal brain development.</p>
<p>Knockdown of glycosyltransferase genes, rather than complete ablation, is another common approach to generate viable postnatal mouse models of α-dystroglycanopathies. For example, various levels of knockdown in <italic>Fkrp</italic> – a glycosyltransferase critical for matriglycan synthesis – mimic the broad clinical variability seen in α-dystroglycanopathies (<xref ref-type="bibr" rid="DMM035931C33">Chan et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C15">Blaeser et al., 2013</xref>). A comparison between <italic>Fkrp</italic>, <italic>Pomgnt1</italic> and <italic>Large</italic> (also known as <italic>Large1</italic>; <xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) mutant mouse strains has elucidated gene-specific phenotypes and exemplifies the utility of these diverse models (<xref ref-type="bibr" rid="DMM035931C18">Booler et al., 2015</xref>).</p>
<p>In addition to mouse models, zebrafish are commonly used owing to their short life cycle and feasibility of targeted gene knockdown with morpholinos (<xref ref-type="table" rid="DMM035931TB5">Table 5</xref>). Although comparisons between zebrafish and human phenotypes are limited, it is a useful strategy for rapidly confirming the functional significance of newly identified genes in α-dystroglycanopathies. Other non-mammalian models include chick, <italic>Xenopus</italic>, <italic>Drosophila</italic> and <italic>Caenorhabditis elegans</italic>, as these systems are amenable for high-throughput genetic screens or allow greater access for experimental manipulation. This abundance of animal models allows for a flexible approach to studying the genetic and phenotypic spectrum of α-dystroglycanopathies.
<table-wrap id="DMM035931TB5" orientation="portrait" position="float"><label>Table 5.</label><caption><p><bold>Non-murine models of α-dystroglycanopathies</bold></p></caption><graphic xlink:href="dmm-11-035931-i5"></graphic></table-wrap></p>
</sec>
<sec id="s5">
<title>α-Dystroglycan and the structural integrity of the nervous system</title>
<sec id="s5a">
<title>Matrix organization</title>
<p>Patients with α-dystroglycanopathy show disruption of basement membranes in both muscle and brain (<xref ref-type="bibr" rid="DMM035931C169">Saito et al., 1999</xref>; <xref ref-type="bibr" rid="DMM035931C201">Vajsar et al., 2000</xref>; <xref ref-type="bibr" rid="DMM035931C57">Goddeeris et al., 2013</xref>). Basement membrane synthesis is believed to begin with soluble extracellular laminin binding to cell membrane galactosyl-sulfatide glycolipids (<xref ref-type="bibr" rid="DMM035931C108">Li et al., 2005</xref>). At high local concentrations, laminins polymerize to form a network at the cell surface, recruiting additional basement membrane proteins and mobilizing integrin and αDG to strengthen the nascent matrix. Thus, αDG is not required for initial basement membrane formation, but likely participates in its maintenance.</p>
<p>As in humans, loss of functional αDG in experimental animal models results in gross malformation to the nervous system, including lissencephaly and hydrocephaly (<xref ref-type="bibr" rid="DMM035931C177">Satz et al., 2010</xref>). Such phenotypes are often accompanied by microscopic ruptures in basement membranes of the neocortex, hippocampus, cerebellum, retina and spinal cord, with abnormal migration of neurons through these breaches (<xref ref-type="bibr" rid="DMM035931C2">Ackroyd et al., 2009</xref>; <xref ref-type="bibr" rid="DMM035931C110">Li et al., 2011</xref>; <xref ref-type="bibr" rid="DMM035931C212">Wright et al., 2012</xref>; <xref ref-type="bibr" rid="DMM035931C139">Nguyen et al., 2013</xref>).</p>
<p>Because <italic>Dag1</italic>-null mouse embryos do not survive gastrulation, other methods have been sought to probe the role of αDG in basement membrane integrity. Mouse embryonic stem cells can be cultured in suspension to form embryoid bodies (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>). An initial report observed complete absence of basement membrane in embryoid bodies derived from <italic>Dag1</italic>-null embryonic stem cells (<xref ref-type="bibr" rid="DMM035931C72">Henry and Campbell, 1998</xref>), but later studies show that such <italic>Dag1</italic>-null embryoid bodies can, in fact, form a basement membrane (<xref ref-type="bibr" rid="DMM035931C107">Li et al., 2002</xref>).</p>
<p>Basement membranes produced in <italic>Dag1</italic>-null embryoid bodies can develop an abnormally thick morphology, suggesting reduced compaction or increased matrix secretion (<xref ref-type="bibr" rid="DMM035931C107">Li et al., 2002</xref>). The epiblast-like cells of embryoid bodies express both αDG and integrin, two major classes of cell surface laminin receptors. In the absence of either receptor, the other can compensate to assemble a basement membrane if high concentrations of laminin proteins are present. However, knockout of both receptors prevents basement membrane formation entirely (<xref ref-type="bibr" rid="DMM035931C111">Li et al., 2017</xref>). Although αDG is not required for the initial polymerization of laminin (<xref ref-type="bibr" rid="DMM035931C108">Li et al., 2005</xref>), it may reinforce and compact the basement membrane through collateral linkages to laminin, agrin and perlecan (<xref ref-type="bibr" rid="DMM035931C57">Goddeeris et al., 2013</xref>).</p>
<p>When <italic>Dag1</italic> knockout is restricted to the epiblast of the developing mouse, the embryo successfully progresses through gastrulation but develops severe malformation of the nervous system (<xref ref-type="bibr" rid="DMM035931C175">Satz et al., 2008</xref>). Interestingly, selective deletion of <italic>Dag1</italic> from various neuron subtypes in NEX-, PCP2- and malpha6 (also known as Tuba1c)-Cre mice, or from the meninges in Wnt1-Cre mice, does not cause nervous system malformation (<xref ref-type="bibr" rid="DMM035931C176">Satz et al., 2009</xref>, <xref ref-type="bibr" rid="DMM035931C177">2010</xref>; <xref ref-type="bibr" rid="DMM035931C80">Hu et al., 2011a</xref>; <xref ref-type="bibr" rid="DMM035931C139">Nguyen et al., 2013</xref>). Likewise, removing the cytoplasmic C-terminus of βDG has no apparent effect (<xref ref-type="bibr" rid="DMM035931C177">Satz et al., 2010</xref>).</p>
<p>However, αDG is highly expressed in glial cells contacting the basement membranes that ensheath the brain, retina and neural vasculature (<xref ref-type="bibr" rid="DMM035931C224">Zaccaria et al., 2001</xref>). Knockout of glial <italic>Dag1</italic> in GFAP-Cre mice leads to fragmentation of basement membranes overlying the cerebral cortex and cerebellum (<xref ref-type="bibr" rid="DMM035931C134">Moore et al., 2002</xref>; <xref ref-type="bibr" rid="DMM035931C177">Satz et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C139">Nguyen et al., 2013</xref>). Various mouse models expressing a hypoglycosylated αDG also show similarly disrupted basement membranes (<xref ref-type="table" rid="DMM035931TB3">Tables 3</xref> and <xref ref-type="table" rid="DMM035931TB4">4</xref>) (<xref ref-type="bibr" rid="DMM035931C131">Michele et al., 2002</xref>; <xref ref-type="bibr" rid="DMM035931C101">Lee et al., 2005</xref>; <xref ref-type="bibr" rid="DMM035931C177">Satz et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C192">Takahashi et al., 2011</xref>). Together, these animal models suggest that αDG has an important receptor function in glial cells involving the integrity of brain ECM structure.</p>
</sec>
<sec id="s5b">
<title>Cortical histogenesis</title>
<p>During mammalian brain development, neuroepithelial cells extend from the ventricular zone to contact the pia mater (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) at the brain's surface (<xref ref-type="bibr" rid="DMM035931C127">McLone, 1980</xref>). These neuroepithelial cells, which later differentiate into radial glia, form a layer of endfoot processes, called the glia limitans, in close apposition to the pia mater (<xref ref-type="fig" rid="DMM035931F3">Fig. 3</xref>B). Meningeal fibroblasts of the pia mater deposit ECM components that are sandwiched to form a basement membrane between the pia mater and underlying glial endfeet (<xref ref-type="bibr" rid="DMM035931C183">Sievers et al., 1994</xref>). Radial glia rely on the basement membrane to maintain their morphology and localization. In turn, they remodel and strengthen its framework through receptor-matrix interactions (<xref ref-type="bibr" rid="DMM035931C182">Sievers et al., 1986</xref>). <italic>In vitro</italic> cultures of meningeal cells and glia spontaneously form basement membrane structures at the interface between the two cell types, demonstrating that both the meninges and glia are necessary for the formation of the pial basement membrane (<xref ref-type="bibr" rid="DMM035931C1">Abnet et al., 1991</xref>; <xref ref-type="bibr" rid="DMM035931C188">Struckhoff, 1995</xref>). Importantly, the pial basement membrane and its associated glial endfeet act as a scaffold for neuronal migration and establishment of the brain's cellular architecture (<xref ref-type="bibr" rid="DMM035931C69">Halfter et al., 2002</xref>).</p>
<p>Ruptures in the pial basement membrane are characteristic of severe forms of α-dystroglycanopathy (<xref ref-type="fig" rid="DMM035931F3">Fig. 3</xref>B). Such ruptures correlate with disorganized glial endfeet and abnormal neuronal migration (<xref ref-type="bibr" rid="DMM035931C78">Hu et al., 2007</xref>; <xref ref-type="bibr" rid="DMM035931C218">Yang et al., 2007</xref>). A common feature is the accumulation of neurons beyond the cortical boundary, presumably due to over-migration through basement membrane breaches (<xref ref-type="bibr" rid="DMM035931C18">Booler et al., 2015</xref>). The underlying cortical plate is also disrupted by irregular neuronal orientation and premature termination of migration, interrupting the two major modes of radial neuronal migration: radial glia-guided and radial glia-independent migration (<xref ref-type="bibr" rid="DMM035931C136">Nakagawa et al., 2015</xref>). This is speculatively due to the apparent disorganization of glial processes and fragmented basement membrane, respectively. Similarly, both the hippocampus and the cerebellum experience neuronal under-migration, resulting in abnormal morphology (<xref ref-type="bibr" rid="DMM035931C114">Liu et al., 2006</xref>; <xref ref-type="bibr" rid="DMM035931C139">Nguyen et al., 2013</xref>). Additional neuronal migration defects can be found in the retina, hindbrain and spinal cord across mouse, zebrafish and <italic>Drosophila</italic> models (<xref ref-type="table" rid="DMM035931TB5">Table 5</xref>) (<xref ref-type="bibr" rid="DMM035931C117">Lunardi et al., 2006</xref>; <xref ref-type="bibr" rid="DMM035931C157">Qu et al., 2006</xref>; <xref ref-type="bibr" rid="DMM035931C181">Shcherbata et al., 2007</xref>; <xref ref-type="bibr" rid="DMM035931C196">Thornhill et al., 2008</xref>; <xref ref-type="bibr" rid="DMM035931C95">Kawahara et al., 2009</xref>; <xref ref-type="bibr" rid="DMM035931C68">Gupta et al., 2011</xref>; <xref ref-type="bibr" rid="DMM035931C120">Marrone et al., 2011a</xref>,<xref ref-type="bibr" rid="DMM035931C121">b</xref>; <xref ref-type="bibr" rid="DMM035931C212">Wright et al., 2012</xref>).</p>
<p>A subset of α-dystroglycanopathy patients develop both pachygyria and polymicrogyria – abnormally thick and thin convolutions of the cerebral cortex, respectively – specifically in the frontal and parietal lobes (<xref ref-type="bibr" rid="DMM035931C4">Aida et al., 1996</xref>; <xref ref-type="bibr" rid="DMM035931C128">Meilleur et al., 2014</xref>; <xref ref-type="bibr" rid="DMM035931C222">Yoshioka et al., 2017</xref>). Occipital subcortical heterotopia, cerebellar cysts and other defects across many brain regions also occur (<xref ref-type="bibr" rid="DMM035931C34">Clement et al., 2008</xref>). In contrast, brain malformations in <italic>Pomgnt1</italic>-null and <italic>Fkrp</italic>(Y307N) mice follow a lateromedial and rostrocaudal gradient of severity. <italic>Large</italic><sup>myd</sup> mice show a more consistent abundance of lesions across the midbrain and cortex (<xref ref-type="bibr" rid="DMM035931C18">Booler et al., 2015</xref>). There are no reports of a lesion gradient in α-dystroglycanopathy patients that match that of <italic>Pomgnt1</italic>-null and <italic>Fkrp</italic>(Y307N) mice. The underlying mechanisms behind such diversity of neural dysplasia (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) between patients and mice are unknown. Remarkably, despite widespread disorganization to the brain's usually laminar architecture, many neurons still differentially express layer-specific markers and project to appropriate brain regions in mouse models (<xref ref-type="bibr" rid="DMM035931C135">Myshrall et al., 2012</xref>). This indicates that some axon pathfinding mechanisms are independent of cortical lamination and may help explain the rather mild cognitive dysfunction in some patients with otherwise extensive brain malformation (<xref ref-type="bibr" rid="DMM035931C58">Godfrey et al., 2007</xref>; <xref ref-type="bibr" rid="DMM035931C128">Meilleur et al., 2014</xref>).</p>
<p>Detailed examination of α-dystroglycanopathy model embryos has highlighted pathologic features that mark the onset of abnormal brain development. In <italic>Pomgnt2</italic>-null and <italic>Fkrp</italic>(Y307N) mice, ectopic movement of Cajal–Retzius cells and subplate neurons through the pial basement membrane occurs as early as embryonic day 10.5 (<xref ref-type="bibr" rid="DMM035931C136">Nakagawa et al., 2015</xref>; <xref ref-type="bibr" rid="DMM035931C19">Booler et al., 2016</xref>). This is followed by cortical plate neurons streaming through the pial ruptures, accumulating beyond the brain's surface in the subarachnoid space. Cajal–Retzius cells orchestrate cortical lamination by secreting reelin (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) (<xref ref-type="bibr" rid="DMM035931C143">Ogawa et al., 1995</xref>). Thus, this early mislocalization of Cajal–Retzius cells might influence later positioning of cortical plate neurons. However, biochemical analyses indicate that there is no perturbation to global reelin signaling in <italic>Pomgnt2</italic>-null and <italic>Fkrp</italic>(Y307N) mouse brains (<xref ref-type="bibr" rid="DMM035931C136">Nakagawa et al., 2015</xref>; <xref ref-type="bibr" rid="DMM035931C19">Booler et al., 2016</xref>).</p>
<p>Meningeal cells of the pia mater and their associated pial basement membrane provide signaling cues and a physical substrate for the migration of Cajal–Retzius cells and other neurons (<xref ref-type="bibr" rid="DMM035931C20">Borrell and Marín, 2006</xref>; <xref ref-type="bibr" rid="DMM035931C180">Sekine et al., 2012</xref>). In α-dystroglycanopathies, the pial basement membrane is believed to form abnormally, potentially rendering it prone to discontinuity and creating a permissive environment for migrating cells to cross its boundary (<xref ref-type="bibr" rid="DMM035931C78">Hu et al., 2007</xref>). Indeed, atomic force microscopy reveals that the retina's inner limiting basement membrane in <italic>Pomgnt1</italic>-null mice is roughly half as stiff and half as thick as that in wild-type mice (<xref ref-type="bibr" rid="DMM035931C79">Hu et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C226">Zhang et al., 2013</xref>). Further, <italic>Pomgnt1</italic>-null neural stem cells demonstrate up to 60% slower accumulation of surface laminin compared with wild type, consistent with reduced ECM assembly by αDG-deficient cells (<xref ref-type="bibr" rid="DMM035931C226">Zhang et al., 2013</xref>).</p>
<p>Interestingly, mutations in ECM receptor genes other than <italic>Dag1</italic> can similarly cause basement membrane breaches. Both GPR56 and integrin-β1 – cell surface receptors of collagen III and laminins, respectively – are expressed on radial glial endfeet abutting the pial basement membrane. Knockout of these receptors causes mislocalization of glial endfeet and aberrant neuronal migration at fragmented regions of the pia mater, ultimately leading to a cobblestone lissencephaly-like cortical dysplasia (<xref ref-type="bibr" rid="DMM035931C63">Graus-Porta et al., 2001</xref>; <xref ref-type="bibr" rid="DMM035931C109">Li et al., 2008</xref>).</p>
<p>Directly perturbing the ECM can also result in pathologic conditions reminiscent of α-dystroglycanopathy. Patients with mutations in laminin subunits α2 and β1 often develop localized cobblestone lissencephaly in the occipital lobe (<xref ref-type="bibr" rid="DMM035931C53">Geranmayeh et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C158">Radmanesh et al., 2013</xref>). In animal models, neuronal migration defects are elicited through the perturbation of laminin-α1, laminin-β2, laminin-γ1, laminin-γ3, collagen III α1, collagen IV α1 or collagen IV α2 (<xref ref-type="bibr" rid="DMM035931C69">Halfter et al., 2002</xref>; <xref ref-type="bibr" rid="DMM035931C155">Pöschl et al., 2004</xref>; <xref ref-type="bibr" rid="DMM035931C118">Luo et al., 2011</xref>; <xref ref-type="bibr" rid="DMM035931C85">Ichikawa-Tomikawa et al., 2012</xref>; <xref ref-type="bibr" rid="DMM035931C159">Radner et al., 2013</xref>).</p>
<p>Because disruption of either ECM receptors or the pia mater ECM itself results in comparable pathology, receptors such as αDG are likely to be involved in physically strengthening the pial basement membrane. However, given that αDG is expressed in a wide array of brain cells beyond radial glia, as discussed in detail below, additional factors are surely necessary to account for all disease-related phenomena seen in patients. This is particularly true for patients with mutations affecting the earliest steps of O-mannosylation, which may affect other glycosylated proteins in addition to αDG (<xref ref-type="bibr" rid="DMM035931C115">Lommel et al., 2013</xref>; <xref ref-type="bibr" rid="DMM035931C204">Vester-Christensen et al., 2013</xref>). However, recent work indicates that cadherins and plexins, two major cell surface receptor families, are not modified by the same O-mannosylation enzymes as αDG (<xref ref-type="bibr" rid="DMM035931C99">Larsen et al., 2017</xref>). Therefore, we consider that the impairment of pial basement membrane integrity from specific loss of αDG-matrix interaction is a likely pathogenic mechanism for the neuronal migration defects in α-dystroglycanopathies.</p>
</sec>
</sec>
<sec id="s6">
<title>Focal organization of the nervous system</title>
<sec id="s6a">
<title>Cell polarity</title>
<p>Although gross malformation to the nervous system is common in α-dystroglycanopathies, increasing evidence suggests perturbation at the subcellular level. Abnormalities in cell polarity, channel distribution and cellular signaling could influence the disease phenotype and be intimately tied to the development of brain dysplasia. As a bridge between extracellular and intracellular elements, αDG and βDG coordinate cytosolic proteins with external cues. Thus, in addition to ECM organization, binding between αDG and its ligands may localize subcellular specializations through interaction with βDG (<xref ref-type="bibr" rid="DMM035931C133">Moore and Winder, 2010</xref>). There is also accumulating evidence that βDG can translocate to the nucleus, regulating nuclear envelope structure and gene expression (<xref ref-type="bibr" rid="DMM035931C122">Martínez-Vieyra et al., 2013</xref>; <xref ref-type="bibr" rid="DMM035931C125">Mathew et al., 2013</xref>; <xref ref-type="bibr" rid="DMM035931C62">Gracida-Jiménez et al., 2017</xref>).</p>
<p>In the embryonic chick retina, DAG1 knockdown induces neuroepithelial stem cell detachment from the inner limiting basement membrane, with a concomitant loss of elongated cell morphology and stalling of apicobasal interkinetic nuclear migration (<xref ref-type="bibr" rid="DMM035931C179">Schröder et al., 2007</xref>). Displacement of molecular markers of epithelial polarity is commonly observed in Dg-null <italic>Drosophila</italic> (<xref ref-type="bibr" rid="DMM035931C42">Deng et al., 2003</xref>; <xref ref-type="bibr" rid="DMM035931C178">Schneider et al., 2006</xref>; <xref ref-type="bibr" rid="DMM035931C181">Shcherbata et al., 2007</xref>). Further, binding between laminin and αDG in mouse embryoid bodies is sufficient to induce polarized morphology of epiblast-like cells and regulate apicobasal orientation (<xref ref-type="bibr" rid="DMM035931C111">Li et al., 2017</xref>). Although the molecular mechanisms have not been precisely defined, there are accumulating data that asymmetrically distributed αDG-laminin interactions can determine cell polarization at basement membrane contact points, perhaps involving cytoplasmic microtubules, CLASP or PAR-1 proteins (<xref ref-type="bibr" rid="DMM035931C124">Masuda-Hirata et al., 2009</xref>; <xref ref-type="bibr" rid="DMM035931C138">Nakaya et al., 2013</xref>).</p>
<p>In the brain and retina, αDG colocalizes with aquaporin-4 water channels and Kir4.1 potassium channels at perivascular glial endfoot processes (<xref ref-type="bibr" rid="DMM035931C66">Guadagno and Moukhles, 2004</xref>). Co-immunoprecipitation experiments showed that both aquaporin-4 and Kir4.1 associate with members of the dystrophin-glycoprotein complex, including βDG (<xref ref-type="bibr" rid="DMM035931C48">Fort et al., 2008</xref>). Binding between αDG and laminin and agrin apparently anchors aquaporin-4 and Kir4.1 within specialized domains at glial endfeet, possibly regulating ion and water homeostasis in the brain (<xref ref-type="bibr" rid="DMM035931C141">Noel et al., 2005</xref>). Animal models of α-dystroglycanopathies accordingly show a deficit of aquaporin-4 and Kir4.1 channels in perivascular glial endfeet (<xref ref-type="bibr" rid="DMM035931C131">Michele et al., 2002</xref>; <xref ref-type="bibr" rid="DMM035931C168">Rurak et al., 2007</xref>; <xref ref-type="bibr" rid="DMM035931C142">Noell et al., 2011</xref>). Notably, deletion of the cytoplasmic C-terminus of βDG is sufficient to reduce Kir4.1 channel clustering in retinal radial glia and produce a reduced electroretinogram b-wave (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>), indicating abnormal visual signal transmission in the retina (<xref ref-type="bibr" rid="DMM035931C176">Satz et al., 2009</xref>). Downregulation of βDG and aquaporin-4 in glial endfeet also occurs after epileptic activity (<xref ref-type="bibr" rid="DMM035931C60">Gondo et al., 2014</xref>). This channel clustering defect may broadly perturb interstitial brain water homeostasis and be linked to white matter abnormalities in α-dystroglycanopathy patients (<xref ref-type="bibr" rid="DMM035931C4">Aida et al., 1996</xref>; <xref ref-type="bibr" rid="DMM035931C39">Cormand et al., 2001</xref>; <xref ref-type="bibr" rid="DMM035931C100">Larson et al., 2018</xref>).</p>
</sec>
<sec id="s6b">
<title>Myelination</title>
<p>In addition to the endfeet of radial and perivascular glia, αDG is expressed in myelinating glia at various stages of maturity (<xref ref-type="bibr" rid="DMM035931C215">Yamada et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C36">Colognato et al., 2007</xref>). White matter alterations are frequently seen on brain magnetic resonance imaging (MRI) scans of α-dystroglycanopathy patients, particularly in those with intellectual deficits (<xref ref-type="bibr" rid="DMM035931C17">Bönnemann et al., 2014</xref>). As discussed in the preceding section, some of these signal alterations may be related to an abnormal water content of the white matter owing to aberrant channel function in radial and perivascular glial endfeet. However, further observations also suggest a pathology of myelinated fiber tracts in α-dystroglycanopathies.</p>
<p>In the peripheral nervous system, αDG localizes to the outer aspect of Schwann cell membranes in contact with the overlying basement membrane and is upregulated during the myelination of regenerating nerves (<xref ref-type="bibr" rid="DMM035931C123">Masaki et al., 2000</xref>). Proper folding of the myelin sheath relies on the collective laminin binding activity of αDG and integrin-α6β4 (<xref ref-type="bibr" rid="DMM035931C140">Nodari et al., 2008</xref>). Additionally, αDG interactions with laminin-211 may guide Schwann cell microvilli to axoglial junctions and thus indirectly mediate sodium channel clustering at the node of Ranvier (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) (<xref ref-type="bibr" rid="DMM035931C170">Saito et al., 2003</xref>). Loss of αDG-laminin binding in mice impairs nerve regeneration, myelination and signal conduction with associated behavioral deficits. In multiple mouse models of α-dystroglycanopathies, researchers reported an axon-sorting defect in the sciatic nerve characterized by amyelinated axon bundles, some of which were large enough to expect myelination (<xref ref-type="bibr" rid="DMM035931C96">Kelly et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C163">Rath et al., 1995</xref>; <xref ref-type="bibr" rid="DMM035931C105">Levedakou et al., 2005</xref>; <xref ref-type="bibr" rid="DMM035931C171">Saito et al., 2007</xref>). This type of pathology might not be a major feature of the human disease, as it has not yet been documented in patients.</p>
<p>In the central nervous system, αDG is expressed on developing oligodendrocytes, where it associates with laminin and IGF-1 signaling proteins, suggesting a role in oligodendrocyte morphological maturation and differentiation (<xref ref-type="bibr" rid="DMM035931C50">Galvin et al., 2010</xref>). Knockout of <italic>Dag1</italic> in neural stem cells compromises the ECM structure of the subventricular zone, a major region of origin for oligodendrocytes, and impedes the maturation of ependymal cells and oligodendrocytes (<xref ref-type="bibr" rid="DMM035931C126">McClenahan et al., 2016</xref>). Further, <italic>in vitro</italic> disruption of αDG-laminin binding leads to decreased filopodia formation and myelination by oligodendrocytes (<xref ref-type="bibr" rid="DMM035931C36">Colognato et al., 2007</xref>; <xref ref-type="bibr" rid="DMM035931C46">Eyermann et al., 2012</xref>). Collectively, these data place αDG as a physical link between the myelinating cell membrane and the ECM, perhaps acting to regulate its proliferation and differentiation or even to stabilize and guide the process of myelination itself.</p>
</sec>
<sec id="s6c">
<title>Organization of the neuromuscular junction</title>
<p>αDG is expressed at peripheral nervous system synapses, where it serves apparent scaffolding functions distinct from that of glial-expressed αDG (<xref ref-type="bibr" rid="DMM035931C14">Bewick et al., 1993</xref>; <xref ref-type="bibr" rid="DMM035931C224">Zaccaria et al., 2001</xref>). A subset of α-dystroglycanopathy patients with mutations in <italic>GMPPB</italic> (<xref ref-type="table" rid="DMM035931TB1">Table 1</xref>) exhibit striking decreases in muscle action potentials during repeated nerve stimulation. Pyridostigmine (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) treatment reportedly improves motor function in these patients, suggesting an abnormality of neuromuscular transmission at the postsynaptic neuromuscular junction (NMJ; <xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) (<xref ref-type="bibr" rid="DMM035931C12">Belaya et al., 2015</xref>; <xref ref-type="bibr" rid="DMM035931C165">Rodríguez Cruz et al., 2016</xref>). However, other α-dystroglycanopathy patients do not show abnormalities, and the reason for these differences remains unknown.</p>
<p>αDG resides at the NMJ postsynaptic membrane and was the first identified receptor of agrin, a master organizer of the NMJ that stimulates acetylcholine receptor (AChR) clustering through its interaction with postsynaptic receptors (<xref ref-type="bibr" rid="DMM035931C21">Bowe et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C28">Campanelli et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C51">Gee et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C191">Sugiyama et al., 1994</xref>). Knockout of <italic>Dag1</italic> in mice does not prevent NMJ formation – instead, NMJs are smaller with fragmented AChR clusters (<xref ref-type="bibr" rid="DMM035931C40">Côté et al., 1999</xref>; <xref ref-type="bibr" rid="DMM035931C87">Jacobson et al., 2001</xref>). This is likely because MuSK (<xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>) is the primary agrin receptor required for NMJ formation, while αDG and βDG appear to be involved in a MuSK-independent mechanism to stabilize AChR clusters (<xref ref-type="bibr" rid="DMM035931C41">DeChiara et al., 1996</xref>; <xref ref-type="bibr" rid="DMM035931C56">Glass et al., 1996</xref>; <xref ref-type="bibr" rid="DMM035931C31">Cartaud et al., 1998</xref>; <xref ref-type="bibr" rid="DMM035931C86">Jacobson et al., 1998</xref>).</p>
<p>In addition to agrin, αDG binds extracellular perlecan at the NMJ (<xref ref-type="bibr" rid="DMM035931C152">Peng et al., 1998</xref>). Perlecan, in turn, binds and stabilizes acetylcholinesterase (AChE) in the synaptic basement membrane (<xref ref-type="bibr" rid="DMM035931C153">Peng et al., 1999</xref>). Because perlecan-null mice show complete absence of AChE at the NMJ, it is possible that neuromuscular transmission in α-dystroglycanopathies may also be impaired by a disruption of an AChE-perlecan-αDG complex (<xref ref-type="bibr" rid="DMM035931C7">Arikawa-Hirasawa et al., 2002</xref>). Chimeric <italic>Dag1</italic>-null mice exhibit reduced levels of AChE at the NMJ (<xref ref-type="bibr" rid="DMM035931C40">Côté et al., 1999</xref>; <xref ref-type="bibr" rid="DMM035931C87">Jacobson et al., 2001</xref>); however, a functional consequence of AChE disruption has not yet been shown in the α-dystroglycanopathies or its models.</p>
</sec>
<sec id="s6d">
<title>Organization of central synapses</title>
<p>In apparent similarity to the NMJ, αDG is also expressed at postsynaptic specializations of the central nervous system (<xref ref-type="bibr" rid="DMM035931C224">Zaccaria et al., 2001</xref>). Cognitive impairment and epilepsy are features in many α-dystroglycanopathies (<xref ref-type="bibr" rid="DMM035931C130">Messina et al., 2009</xref>; <xref ref-type="bibr" rid="DMM035931C43">Di Rosa et al., 2011</xref>; <xref ref-type="bibr" rid="DMM035931C8">Astrea et al., 2018</xref>; <xref ref-type="bibr" rid="DMM035931C100">Larson et al., 2018</xref>). For some patients, MRI shows grossly normal brain morphology despite significant cognitive deficits (<xref ref-type="bibr" rid="DMM035931C58">Godfrey et al., 2007</xref>; <xref ref-type="bibr" rid="DMM035931C34">Clement et al., 2008</xref>; <xref ref-type="bibr" rid="DMM035931C90">Jimenez-Mallebrera et al., 2009</xref>). This observation suggests a neuronal dysfunction below the detection limit of current brain imaging tools, such as central synaptic dysfunction, for example.</p>
<p>The expression of αDG in central neurons is restricted to a subset of postsynaptic sites in pyramidal cells of the cerebral cortex and hippocampus as well as cerebellar Purkinje cells (<xref ref-type="bibr" rid="DMM035931C224">Zaccaria et al., 2001</xref>). Immunolabeling of murine hippocampal cultures reveals a selective association between αDG and postsynaptic proteins of γ-aminobutyric acid (GABA) inhibitory synapses: dystrophin, GAD, gephyrin and GABA<sub>A</sub> receptor subunits α1, β2/3 and γ2 (<xref ref-type="bibr" rid="DMM035931C26">Brünig et al., 2002</xref>; <xref ref-type="bibr" rid="DMM035931C106">Lévi et al., 2002</xref>; <xref ref-type="bibr" rid="DMM035931C156">Pribiag et al., 2014</xref>). Because αDG is an extracellular membrane-associated protein, it is reasonable to speculate that it may act as part of a trans-synaptic protein complex, perhaps facilitating synapse formation or maintenance. Indeed, characterized ligands of αDG, agrin and the neurexin proteins, are expressed at presynaptic terminals in the brain where they may interact across the synapse with matriglycans on postsynaptic αDG (<xref ref-type="bibr" rid="DMM035931C47">Ferreira, 1999</xref>; <xref ref-type="bibr" rid="DMM035931C190">Sugita et al., 2001</xref>).</p>
<p>The NEX-Cre/DG-null mouse, in which <italic>Dag1</italic> is conditionally deleted from pyramidal neurons, shows virtually complete loss of cholecystokinin (CCK) GABAergic presynaptic terminals (<xref ref-type="bibr" rid="DMM035931C49">Fruh et al., 2016</xref>). Despite this selective loss of presynaptic input, there is no change in the total number of GABAergic presynaptic terminals, suggesting a compensatory effect. This is consistent with the <italic>in vitro</italic> observation that <italic>Dag1</italic> knockout does not affect overall GABAergic synapse numbers (<xref ref-type="bibr" rid="DMM035931C106">Lévi et al., 2002</xref>). Knockout of <italic>Dag1</italic> after synapse formation in adult animals likewise causes selective loss of CCK terminals, but there is no such phenotype in the <italic>Dag1</italic> T190M knock-in mouse – a model of α-dystroglycanopathy expressing a neurexin-binding-deficient αDG (<xref ref-type="bibr" rid="DMM035931C49">Fruh et al., 2016</xref>). Because this process appears independent from αDG-neurexin binding, αDG may interact with additional unidentified presynaptic receptors or indirectly control other trans-synaptic proteins to facilitate CCK GABAergic innervation.</p>
<p>In primary hippocampal cultures, a pharmacological increase in neuronal firing rate induces a compensatory boost in inhibitory synaptic strength, accompanied by increased clustering of αDG and GABA<sub>A</sub>Rs at the postsynaptic surface (<xref ref-type="bibr" rid="DMM035931C156">Pribiag et al., 2014</xref>). Interestingly, this inhibitory upscaling is partly reproduced by the addition of agrin to the culture medium, and it is blocked by knockdown of <italic>Dag1</italic> or the glycosyltransferase Large, demonstrating that the receptor function of αDG is required for this form of homeostatic synaptic plasticity. The inhibitory synaptic defects identified in mouse and cellular models may explain the epilepsy seen in patients (<xref ref-type="bibr" rid="DMM035931C156">Pribiag et al., 2014</xref>; <xref ref-type="bibr" rid="DMM035931C49">Fruh et al., 2016</xref>). However, future work must delineate the various biochemical interactions of αDG and βDG and their potential roles in synapse formation versus synapse plasticity.</p>
</sec>
<sec id="s6e">
<title>Organization of retinal synapses</title>
<p>While αDG resides at the postsynaptic apparatus of some central synapses and the NMJ, it assumes a unique presynaptic position in the retina. Early work identified αDG and βDG, in association with dystrophin, within the outer plexiform layer, where presynaptic photoreceptor terminals contact postsynaptic bipolar and horizontal cells (<xref ref-type="bibr" rid="DMM035931C132">Montanaro et al., 1995</xref>). Interestingly, both α-dystroglycanopathy patients and animal models present abnormal electroretinograms (ERGs; <xref ref-type="boxed-text" rid="DMM035931B2">Box 2</xref>), indicating retinal dysfunction (<xref ref-type="bibr" rid="DMM035931C77">Holzfeind et al., 2002</xref>; <xref ref-type="bibr" rid="DMM035931C193">Takeda et al., 2003</xref>; <xref ref-type="bibr" rid="DMM035931C101">Lee et al., 2005</xref>). Some patients, in particular those with the <italic>POMGNT1</italic> mutations prevalent in Finnish MEB patients, show overt evidence for retinal degeneration (<xref ref-type="bibr" rid="DMM035931C173">Santavuori et al., 1989</xref>; <xref ref-type="bibr" rid="DMM035931C154">Pihko et al., 1995</xref>).</p>
<p>The synaptic ligand of αDG in the retina, encoded by pikachurin (also known as <italic>Egflam</italic>), was discovered in a transcriptomic screen comparing retinas from wild-type and <italic>Otx2</italic>-null mice, a mouse strain lacking photoreceptor cells (<xref ref-type="bibr" rid="DMM035931C174">Sato et al., 2008</xref>). Pikachurin localizes to the synaptic cleft of the specialized ribbon synapse between photoreceptor and bipolar cells. There, it binds the matriglycans on αDG to link presynaptic rod/cone photoreceptors to the postsynaptic bipolar cell dendrite, allowing for rapid communication across the first synapse in the visual system (<xref ref-type="bibr" rid="DMM035931C93">Kanagawa et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C81">Hu et al., 2011b</xref>). A recent analysis demonstrates that pikachurin acts as a trans-synaptic bridge, physically joining presynaptic αDG to the postsynaptic orphan receptor GPR179 (<xref ref-type="bibr" rid="DMM035931C145">Orlandi et al., 2018</xref>).</p>
<p>Pikachurin and αDG are mutually required for proper localization, because ablation of either causes a significant reduction to the other (<xref ref-type="bibr" rid="DMM035931C144">Omori et al., 2012</xref>). Ultrastructurally, loss of the photoreceptor αDG-pikachurin complex leads to abnormal synapse formation between photoreceptors and bipolar cells (<xref ref-type="bibr" rid="DMM035931C174">Sato et al., 2008</xref>; <xref ref-type="bibr" rid="DMM035931C144">Omori et al., 2012</xref>; <xref ref-type="bibr" rid="DMM035931C167">Rubio-Fernández et al., 2018</xref>). This uncoupling of the photoreceptor from the bipolar cell was confirmed by ERG in both mice and patients, where the a-wave is unimpaired but the b-wave exhibits a significantly attenuated amplitude (<xref ref-type="bibr" rid="DMM035931C173">Santavuori et al., 1989</xref>; <xref ref-type="bibr" rid="DMM035931C154">Pihko et al., 1995</xref>; <xref ref-type="bibr" rid="DMM035931C116">Longman et al., 2003</xref>; <xref ref-type="bibr" rid="DMM035931C174">Sato et al., 2008</xref>; <xref ref-type="bibr" rid="DMM035931C144">Omori et al., 2012</xref>; <xref ref-type="bibr" rid="DMM035931C167">Rubio-Fernández et al., 2018</xref>).</p>
</sec>
</sec>
<sec id="s7">
<title>Conclusions and perspective</title>
<p>Based on the wealth of data now available from various experimental animal models, we propose at least two broad, but distinct, categories of nervous system pathology in α-dystroglycanopathies: (1) a histological abnormality arising from dysfunction of glial αDG, largely responsible for the distinctive migration abnormalities during brain development and white matter changes; and (2) a synaptic defect from dysfunction of neuronal αDG. α-Dystroglycanopathy patients often present with intellectual deficits presumably caused by developmental brain malformation. However, an increasingly recognized subset of patients present with significant cognitive delays but normal or near-normal brain structure as determined by MRI (<xref ref-type="bibr" rid="DMM035931C58">Godfrey et al., 2007</xref>; <xref ref-type="bibr" rid="DMM035931C34">Clement et al., 2008</xref>; <xref ref-type="bibr" rid="DMM035931C90">Jimenez-Mallebrera et al., 2009</xref>). We hypothesize that these individuals may harbor a selective defect at the synapse level that contributes to their cognitive dysfunction. This will be important to identify, as synaptic pathology could potentially be amenable to treatments that are targeted at improved αDG function (<xref ref-type="boxed-text" rid="DMM035931B4">Box 4</xref>).
<boxed-text id="DMM035931B4" orientation="portrait" position="float"><caption><title>Box 4. Therapeutic approaches for α-dystroglycanopathies</title></caption><p>Animal models are an important pre-clinical platform for α-dystroglycanopathy therapy development. Forced overexpression of wild-type <italic>LARGE</italic>, the glycosyltransferase directly responsible for matriglycan synthesis, has been shown to restore αDG glycosylation (<xref ref-type="bibr" rid="DMM035931C11">Barresi et al., 2004</xref>). This approach significantly increases αDG-laminin binding and improves muscle function in the <italic>Large</italic><sup>myd</sup> mouse (<xref ref-type="bibr" rid="DMM035931C11">Barresi et al., 2004</xref>; <xref ref-type="bibr" rid="DMM035931C75">Hildyard et al., 2016</xref>). This therapeutic strategy may extend to multiple forms of α-dystroglycanopathy, as <italic>LARGE</italic> overexpression enhances αDG glycosylation in human cells and mouse models with mutations in <italic>POMT1</italic>, <italic>POMGNT1</italic>, <italic>FKTN</italic> and <italic>FKRP</italic> (<xref ref-type="bibr" rid="DMM035931C11">Barresi et al., 2004</xref>; <xref ref-type="bibr" rid="DMM035931C223">Yu et al., 2013</xref>; <xref ref-type="bibr" rid="DMM035931C202">Vannoy et al., 2014</xref>). However, <italic>LARGE</italic> replacement therapy in <italic>Fktn</italic>- and <italic>Fkrp</italic>-null mice has also been shown to worsen muscle pathology (<xref ref-type="bibr" rid="DMM035931C208">Whitmore et al., 2013</xref>; <xref ref-type="bibr" rid="DMM035931C172">Saito et al., 2014</xref>). These conflicting results warrant further investigation into glycosylation-modulating therapies before moving to the clinic.</p><p>The post-translational addition of ribitol to αDG is a precursor step to matriglycan synthesis. Because this process is catalyzed by ISPD, FKTN and FKRP, α-dystroglycanopathy patients carrying mutations in these enzymes might benefit from ribitol treatment. Encouragingly, supplementation of ribitol in cell culture medium enhances αDG glycosylation in <italic>ISPD</italic> mutant cells (<xref ref-type="bibr" rid="DMM035931C54">Gerin et al., 2016</xref>; <xref ref-type="bibr" rid="DMM035931C94">Kanagawa et al., 2016</xref>), and dietary administration in <italic>Fkrp</italic>(P448L) mice diminishes skeletal muscle phenotypes (<xref ref-type="bibr" rid="DMM035931C32">Cataldi et al., 2018</xref>).</p><p>Restoring αDG glycosylation could also ameliorate the intellectual deficits associated with α-dystroglycanopathies. Transgenic expression or gene delivery of glycosyltransferases in the brain restores wild-type levels of glycosylation to αDG and prevents abnormal cortical development in mouse models (<xref ref-type="bibr" rid="DMM035931C75">Hildyard et al., 2016</xref>; <xref ref-type="bibr" rid="DMM035931C189">Sudo et al., 2018</xref>). Further, postnatal AAV9-mediated gene delivery of wild-type <italic>Dag1</italic> improved cognitive function in the Emx1-Cre/<italic>Pomt2</italic>-null mouse, despite persistent cortical dysplasia (<xref ref-type="bibr" rid="DMM035931C82">Hu et al., 2016</xref>). This promising result suggests that even patients with considerable brain malformation may experience behavioral improvement with therapy.</p></boxed-text></p>
<p>Few studies have comprehensively assessed cognitive ability in α-dystroglycanopathies, but some reports indicate impaired executive control, memory and visuospatial attention in patients with macroscopically normal brain structure or minimal brain malformation (<xref ref-type="bibr" rid="DMM035931C146">Palmieri et al., 2011</xref>; <xref ref-type="bibr" rid="DMM035931C128">Meilleur et al., 2014</xref>). The <italic>Large</italic><sup>myd</sup> and Emx1-Cre/DG-null mouse models of α-dystroglycanopathy similarly show a memory consolidation deficit (<xref ref-type="bibr" rid="DMM035931C37">Comim et al., 2013</xref>, <xref ref-type="bibr" rid="DMM035931C38">2014</xref>; <xref ref-type="bibr" rid="DMM035931C82">Hu et al., 2016</xref>). Attention and memory are correlated with gamma oscillations of 30-80 Hz in the cortex – a frequency of electrical activity synchronized partly by CCK interneurons (<xref ref-type="bibr" rid="DMM035931C45">Engel et al., 2001</xref>; <xref ref-type="bibr" rid="DMM035931C198">Tukker et al., 2007</xref>). Interestingly, as discussed earlier, the NEX-Cre/DG-null mouse displays a selective loss of CCK GABAergic synaptic inputs (<xref ref-type="bibr" rid="DMM035931C49">Fruh et al., 2016</xref>). Considering these results, gamma oscillations could be studied in α-dystroglycanopathies, especially given that abnormal gamma oscillations have already been reported in other brain disorders, including autism, epilepsy and schizophrenia (<xref ref-type="bibr" rid="DMM035931C200">Uhlhaas and Singer, 2006</xref>). The NEX-Cre/DG-null line is particularly suited to these investigations, as it avoids the confounding factor of brain malformation by selective knockout of neuronal <italic>Dag1</italic>.</p>
<p>Much is still unknown about the role of dystroglycan in the nervous system, particularly regarding its putative functions in neurons of the olfactory bulb, thalamus, hypothalamus and brainstem (<xref ref-type="bibr" rid="DMM035931C61">Górecki et al., 1994</xref>; <xref ref-type="bibr" rid="DMM035931C224">Zaccaria et al., 2001</xref>). Further use of inducible <italic>Dag1</italic> knockout models and precise domain deletions is crucial to expand our understanding of the specific roles for αDG and βDG in both developing and mature cell types. Additional factors are possibly at play in the dystroglycan-deficient brain that are not discussed in this Review, including aberrant energy metabolism and cholinergic signaling (<xref ref-type="bibr" rid="DMM035931C160">Rae et al., 1998</xref>, <xref ref-type="bibr" rid="DMM035931C161">2002</xref>; <xref ref-type="bibr" rid="DMM035931C194">Takeuchi et al., 2009</xref>; <xref ref-type="bibr" rid="DMM035931C199">Tuon et al., 2010</xref>; <xref ref-type="bibr" rid="DMM035931C149">Parames et al., 2014</xref>). In future work, parsing the relationship between these pathologic elements should clarify the functional roles of dystroglycan and elucidate the order of events in its dysfunction. Continued study and development of clinically relevant animal models will be a key endeavor in understanding the basic functions of αDG in the nervous system and in designing rational therapies for α-dystroglycanopathies.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We thank Kristen Zukosky and Michelle Lee for their helpful discussion and insight.</p>
</ack>
<fn-group>
<title>Footnotes</title>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare no competing or financial interests.</p>
</fn>
<fn fn-type="financial-disclosure">
<p>
<bold>Funding</bold>
</p>
<p>Research on α-dystroglycanopathies in the Bönnemann laboratory is supported by US National Institutes of Health Intramural Research Program funding from the National Institute of Neurological Disorders and Stroke.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="DMM035931C1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abnet</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Fawcett</surname><given-names>J. W.</given-names></name> and <name name-style="western"><surname>Dunnett</surname><given-names>S. B.</given-names></name></person-group> (<year>1991</year>). <article-title>Interactions between meningeal cells and astrocytes in vivo and in vitro</article-title>. <source/><italic toggle="yes">Dev. Brain Res.</italic>
<volume>59</volume>, <fpage>187</fpage>-<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1016/0165-3806(91)90099-5</pub-id><pub-id pub-id-type="pmid">1717179</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ackroyd</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Skordis</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kaluarachchi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Godwin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Prior</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fidanboylu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Piercy</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Muntoni</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Brown</surname><given-names>S. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Reduced expression of fukutin related protein in mice results in a model for fukutin related protein associated muscular dystrophies</article-title>. <source/><italic toggle="yes">Brain</italic>
<volume>132</volume>, <fpage>439</fpage>-<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awn335</pub-id><pub-id pub-id-type="pmid">19155270</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ackroyd</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Whitmore</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Prior</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kaluarachchi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Nikolic</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mayer</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Muntoni</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Brown</surname><given-names>S. C.</given-names></name></person-group> (<year>2011</year>). <article-title>Fukutin-related protein alters the deposition of laminin in the eye and brain</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>31</volume>, <fpage>12927</fpage>-<lpage>12935</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2301-11.2011</pub-id><pub-id pub-id-type="pmid">21900571</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aida</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tamagawa</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Takada</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yagishita</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Chikumaru</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Iwamoto</surname><given-names>H.</given-names></name></person-group> (<year>1996</year>). <article-title>Brain MR in Fukuyama congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Am. J. Neuroradiol.</italic>
<volume>17</volume>, <fpage>605</fpage>-<lpage>613</lpage>.<pub-id pub-id-type="pmid">8730178</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akhavan</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Crivelli</surname><given-names>S. N.</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lingappa</surname><given-names>V. R.</given-names></name> and <name name-style="western"><surname>Muschler</surname><given-names>J. L.</given-names></name></person-group> (<year>2008</year>). <article-title>SEA domain proteolysis determines the functional composition of dystroglycan</article-title>. <source/><italic toggle="yes">FASEB J.</italic>
<volume>22</volume>, <fpage>612</fpage>-<lpage>621</lpage>. <pub-id pub-id-type="doi">10.1096/fj.07-8354com</pub-id><pub-id pub-id-type="pmid">17905726</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alhamidi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Brox</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Stensland</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Liset</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lindal</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Nilssen</surname><given-names>Ø.</given-names></name></person-group> (<year>2017</year>). <article-title>Limb girdle muscular dystrophy type 2I: No correlation between clinical severity, histopathology and glycosylated α-dystroglycan levels in patients homozygous for common FKRP mutation</article-title>. <source/><italic toggle="yes">Neuromuscul. Disord.</italic>
<volume>27</volume>, <fpage>619</fpage>-<lpage>626</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2017.02.015</pub-id><pub-id pub-id-type="pmid">28479227</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arikawa-Hirasawa</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Rossi</surname><given-names>S. G.</given-names></name>, <name name-style="western"><surname>Rotundo</surname><given-names>R. L.</given-names></name> and <name name-style="western"><surname>Yamada</surname><given-names>Y.</given-names></name></person-group> (<year>2002</year>). <article-title>Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice</article-title>. <source/><italic toggle="yes">Nat. Neurosci.</italic>
<volume>5</volume>, <fpage>119</fpage>-<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1038/nn801</pub-id><pub-id pub-id-type="pmid">11802174</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Astrea</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Romano</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Angelini</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Antozzi</surname><given-names>C. G.</given-names></name>, <name name-style="western"><surname>Barresi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Battini</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Battisti</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bertini</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cassandrini</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>). <article-title>Broad phenotypic spectrum and genotype- phenotype correlations in GMPPB -related dystroglycanopathies: an Italian cross- sectional study</article-title>. <source/><italic toggle="yes">Orphanet J. Rare Dis.</italic>
<volume>13</volume>, <fpage>170</fpage>
<pub-id pub-id-type="doi">10.1186/s13023-018-0863-x</pub-id><pub-id pub-id-type="pmid">30257713</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avşar-Ban</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Manya</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Watanabe</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Akiyama</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Endo</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Tamaru</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Protein O-mannosylation is necessary for normal embryonic development in zebrafish</article-title>. <source/><italic toggle="yes">Glycobiology</italic>
<volume>20</volume>, <fpage>1089</fpage>-<lpage>1102</lpage>. <pub-id pub-id-type="doi">10.1093/glycob/cwq069</pub-id><pub-id pub-id-type="pmid">20466645</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barone</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Aiello</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Race</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Morava</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Foulquier</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Riemersma</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Passarelli</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Concolino</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Carella</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Santorelli</surname><given-names>F.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>DPM2-CDG: a muscular dystrophy–dystroglycanopathy syndrome with severe epilepsy</article-title>. <source/><italic toggle="yes">Ann. Neurol.</italic>
<volume>72</volume>, <fpage>550</fpage>-<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1002/ana.23632</pub-id><pub-id pub-id-type="pmid">23109149</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barresi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Michele</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Harper</surname><given-names>H. A.</given-names></name>, <name name-style="western"><surname>Dovico</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Satz</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Schachter</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Dumanski</surname><given-names>J. P.</given-names></name><etal>et al.</etal></person-group> (<year>2004</year>). <article-title>LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies</article-title>. <source/><italic toggle="yes">Nat. Med.</italic>
<volume>10</volume>, <fpage>696</fpage>-<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1038/nm1059</pub-id><pub-id pub-id-type="pmid">15184894</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Belaya</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Rodríguez Cruz</surname><given-names>P. M.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W. W.</given-names></name>, <name name-style="western"><surname>Maxwell</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>McGowan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Farrugia</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Petty</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Walls</surname><given-names>T. J.</given-names></name>, <name name-style="western"><surname>Sedghi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Basiri</surname><given-names>K.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies</article-title>. <source/><italic toggle="yes">Brain</italic>
<volume>138</volume>, <fpage>2493</fpage>-<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv185</pub-id><pub-id pub-id-type="pmid">26133662</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Beltrán-Valero de Bernabé</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Currier</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Steinbrecher</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Celli</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>van Beusekom</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>van der Zwaag</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kayserili</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Merlini</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Chitayat</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Dobyns</surname><given-names>W. B.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>). <article-title>Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder walker-warburg syndrome</article-title>. <source/><italic toggle="yes">Am. J. Hum. Genet.</italic>
<volume>71</volume>, <fpage>1033</fpage>-<lpage>1043</lpage>. <pub-id pub-id-type="doi">10.1086/342975</pub-id><pub-id pub-id-type="pmid">12369018</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bewick</surname><given-names>G. S.</given-names></name>, <name name-style="western"><surname>Nicholson</surname><given-names>L. V. B.</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Slater</surname><given-names>C. R.</given-names></name></person-group> (<year>1993</year>). <article-title>Relationship of a dystrophin-associated glycoprotein to junctional acetylcholine receptor clusters in rat skeletal muscle</article-title>. <source/><italic toggle="yes">Neuromuscul. Disord.</italic>
<volume>3</volume>, <fpage>503</fpage>-<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/0960-8966(93)90105-S</pub-id><pub-id pub-id-type="pmid">8186701</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blaeser</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Keramaris</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>Y. M.</given-names></name>, <name name-style="western"><surname>Sparks</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Cowley</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes</article-title>. <source/><italic toggle="yes">Hum. Genet.</italic>
<volume>132</volume>, <fpage>923</fpage>-<lpage>934</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-013-1302-7</pub-id><pub-id pub-id-type="pmid">23591631</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Blaeser</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Awano</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Lu</surname><given-names>Q.-L.</given-names></name></person-group> (<year>2018</year>). <article-title>Distinct expression of functionally glycosylated alpha-dystroglycan in muscle and non-muscle tissues of FKRP mutant mice</article-title>. <source/><italic toggle="yes">PLoS ONE</italic>
<volume>13</volume>, <fpage>e0191016</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0191016</pub-id><pub-id pub-id-type="pmid">29320543</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bönnemann</surname><given-names>C. G.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>C. H.</given-names></name>, <name name-style="western"><surname>Quijano-Roy</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Deconinck</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Bertini</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ferreiro</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Muntoni</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Sewry</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Béroud</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mathews</surname><given-names>K. D.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Diagnostic approach to the congenital muscular dystrophies</article-title>. <source/><italic toggle="yes">Neuromuscul. Disord.</italic>
<volume>24</volume>, <fpage>289</fpage>-<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2013.12.011</pub-id><pub-id pub-id-type="pmid">24581957</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Booler</surname><given-names>H. S.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Hopkinson</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Brown</surname><given-names>S. C.</given-names></name></person-group> (<year>2015</year>). <article-title>Degree of Cajal-Retzius cell mislocalisation correlates with the severity of structural brain defects in mouse models of dystroglycanopathy</article-title>. <source/><italic toggle="yes">Brain Pathol.</italic>
<volume>26</volume>, <fpage>465</fpage>-<lpage>478</lpage>. <pub-id pub-id-type="doi">10.1111/bpa.12306</pub-id><pub-id pub-id-type="pmid">26306834</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Booler</surname><given-names>H. S.</given-names></name>, <name name-style="western"><surname>Pagalday-Vergara</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Hopkinson</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Brown</surname><given-names>S. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Evidence of early defects in Cajal Retzius cell localisation during brain development in a mouse model of dystroglycanopathy</article-title>. <source/><italic toggle="yes">Neuropathol. Appl. Neurobiol.</italic>
<volume>43</volume>, <fpage>330</fpage>-<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1111/nan.12376</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Borrell</surname><given-names>V.</given-names></name> and <name name-style="western"><surname>Marín</surname><given-names>O.</given-names></name></person-group> (<year>2006</year>). <article-title>Meninges control tangential migration of hem-derived Cajal-Retzius cells via CXCL12/CXCR4 signaling</article-title>. <source/><italic toggle="yes">Nat. Neurosci.</italic>
<volume>9</volume>, <fpage>1284</fpage>-<lpage>1293</lpage>. <pub-id pub-id-type="doi">10.1038/nn1764</pub-id><pub-id pub-id-type="pmid">16964252</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowe</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Deyst</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Leszyk</surname><given-names>J. D.</given-names></name> and <name name-style="western"><surname>Fallon</surname><given-names>J. R.</given-names></name></person-group> (<year>1994</year>). <article-title>Identification and purification of an agrin receptor from torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>12</volume>, <fpage>1173</fpage>-<lpage>1180</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(94)90324-7</pub-id><pub-id pub-id-type="pmid">8185951</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brancaccio</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Schulthess</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Gesemann</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Engel</surname><given-names>J.</given-names></name></person-group> (<year>1995</year>). <article-title>Electron microscopic evidence for a mucin-like region in chick muscle α-dystroglycan</article-title>. <source/><italic toggle="yes">FEBS Lett.</italic>
<volume>368</volume>, <fpage>139</fpage>-<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(95)00628-M</pub-id><pub-id pub-id-type="pmid">7615068</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brancaccio</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Schulthess</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Gesemann</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Engel</surname><given-names>J.</given-names></name></person-group> (<year>1997</year>). <article-title>The N-terminal region of alpha-dystroglycan is an autonomous globular domain</article-title>. <source/><italic toggle="yes">Eur. J. Biochem.</italic>
<volume>246</volume>, <fpage>166</fpage>-<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-1033.1997.00166.x</pub-id><pub-id pub-id-type="pmid">9210479</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Briggs</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Strazzulli</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Moracci</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Yoshida-Moriguchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Zheng</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Venzke</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hohenester</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>2016</year>). <article-title>Structural basis of laminin binding to the LARGE glycans on dystroglycan</article-title>. <source/><italic toggle="yes">Nat.Chem.Biol.</italic>
<volume>12</volume>, <fpage>810</fpage>-<lpage>814</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.2146</pub-id><pub-id pub-id-type="pmid">27526028</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brockington</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Blake</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Prandini</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Torelli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Ponting</surname><given-names>C. P.</given-names></name>, <name name-style="western"><surname>Estournet</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Romero</surname><given-names>N. B.</given-names></name>, <name name-style="western"><surname>Mercuri</surname><given-names>E.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>). <article-title>Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan</article-title>. <source/><italic toggle="yes">Am. J. Hum. Genet.</italic>
<volume>69</volume>, <fpage>1198</fpage>-<lpage>1209</lpage>. <pub-id pub-id-type="doi">10.1086/324412</pub-id><pub-id pub-id-type="pmid">11592034</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brünig</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Suter</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Knuesel</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Lüscher</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Fritschy</surname><given-names>J.-M.</given-names></name></person-group> (<year>2002</year>). <article-title>GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>22</volume>, <fpage>4805</fpage>-<lpage>4813</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-12-04805.2002</pub-id><pub-id pub-id-type="pmid">12077177</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Buysse</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Riemersma</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Powell</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>van Reeuwijk</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chitayat</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Roscioli</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kamsteeg</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>van den Elzen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>van Beusekom</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Blaser</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Missense mutations in beta-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>22</volume>, <fpage>1746</fpage>-<lpage>1754</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt021</pub-id><pub-id pub-id-type="pmid">23359570</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Campanelli</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>Roberds</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name> and <name name-style="western"><surname>Scheller</surname><given-names>R. H.</given-names></name></person-group> (<year>1994</year>). <article-title>A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering</article-title>. <source/><italic toggle="yes">Cell</italic>
<volume>77</volume>, <fpage>663</fpage>-<lpage>674</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(94)90051-5</pub-id><pub-id pub-id-type="pmid">8205616</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cao</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Borrow</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Elder</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Ravkov</surname><given-names>E. V.</given-names></name>, <name name-style="western"><surname>Nichol</surname><given-names>S. T.</given-names></name>, <name name-style="western"><surname>Compans</surname><given-names>R. W.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name> and <name name-style="western"><surname>Oldstone</surname><given-names>M. B. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and lassa fever virus</article-title>. <source/><italic toggle="yes">Science</italic>
<volume>282</volume>, <fpage>2079</fpage>-<lpage>2081</lpage>. <pub-id pub-id-type="doi">10.1126/science.282.5396.2079</pub-id><pub-id pub-id-type="pmid">9851928</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Carss</surname><given-names>K. J.</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Foley</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Cirak</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Riemersma</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Torelli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Hoischen</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Willer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>van Scherpenzeel</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan</article-title>. <source/><italic toggle="yes">Am. J. Hum. Genet.</italic>
<volume>93</volume>, <fpage>29</fpage>-<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.05.009</pub-id><pub-id pub-id-type="pmid">23768512</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cartaud</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Coutant</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Petrucci</surname><given-names>T. C.</given-names></name> and <name name-style="western"><surname>Cartaud</surname><given-names>J.</given-names></name></person-group> (<year>1998</year>). <article-title>Evidence for in situ and in vitro association between β-dystroglycan and the subsynaptic 43k rapsyn protein</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>273</volume>, <fpage>11321</fpage>-<lpage>11326</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.18.11321</pub-id><pub-id pub-id-type="pmid">9556625</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cataldi</surname><given-names>M. P.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Blaeser</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Lu</surname><given-names>Q. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Ribitol restores functionally glycosylated α-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice</article-title>. <source/><italic toggle="yes">Nat. Commun.</italic>
<volume>9</volume>, <fpage>3448</fpage>
<pub-id pub-id-type="doi">10.1038/s41467-018-05990-z</pub-id><pub-id pub-id-type="pmid">30150693</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chan</surname><given-names>Y. M.</given-names></name>, <name name-style="western"><surname>Keramaris-Vrantsis</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lidov</surname><given-names>H. G.</given-names></name>, <name name-style="western"><surname>Norton</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Zinchenko</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Gruber</surname><given-names>H. E.</given-names></name>, <name name-style="western"><surname>Thresher</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Blake</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Ashar</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rosenfeld</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>19</volume>, <fpage>3995</fpage>-<lpage>4006</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq314</pub-id><pub-id pub-id-type="pmid">20675713</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Clement</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mercuri</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Godfrey</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Robb</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kinali</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Straub</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Bushby</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Manzur</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Talim</surname><given-names>B.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Brain involvement in muscular dystrophies with defective dystroglycan glycosylation</article-title>. <source/><italic toggle="yes">Ann. Neurol.</italic>
<volume>64</volume>, <fpage>573</fpage>-<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1002/ana.21482</pub-id><pub-id pub-id-type="pmid">19067344</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohn</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Michele</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Barresi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Flanagan</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Skwarchuk</surname><given-names>M. W.</given-names></name>, <name name-style="western"><surname>Robbins</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Mendell</surname><given-names>J. R.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>). <article-title>Disruption of Dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration</article-title>. <source/><italic toggle="yes">Cell</italic>
<volume>110</volume>, <fpage>639</fpage>-<lpage>648</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(02)00907-8</pub-id><pub-id pub-id-type="pmid">12230980</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colognato</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Galvin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Relucio</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Yurchenco</surname><given-names>P. D.</given-names></name> and <name name-style="western"><surname>Ffrench-Constant</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Identification of dystroglycan as a second laminin receptor in oligodendrocytes, with a role in myelination</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>134</volume>, <fpage>1723</fpage>-<lpage>1736</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02819</pub-id><pub-id pub-id-type="pmid">17395644</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Comim</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>MendonÇa</surname><given-names>B. P.</given-names></name>, <name name-style="western"><surname>Dominguini</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Cipriano</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Steckert</surname><given-names>A. V.</given-names></name>, <name name-style="western"><surname>Scaini</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Vainzof</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Streck</surname><given-names>E. L.</given-names></name>, <name name-style="western"><surname>Dal-Pizzol</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Quevedo</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Central nervous system involvement in the animal model of myodystrophy</article-title>. <source/><italic toggle="yes">Mol. Neurobiol.</italic>
<volume>48</volume>, <fpage>71</fpage>-<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-013-8415-9</pub-id><pub-id pub-id-type="pmid">23508358</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Comim</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Schactae</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Soares</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Behavioral responses in animal model of congenital muscular dystrophy 1D</article-title>. <source/><italic toggle="yes">Mol. Neurobiol.</italic>
<volume>53</volume>, <fpage>402</fpage>-<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-9024-y</pub-id><pub-id pub-id-type="pmid">25465243</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cormand</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Pihko</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bayes</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Valanne</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Santavuori</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Talim</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Gershoni-Baruch</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ahmad</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>van Bokhoven</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Brunner</surname><given-names>H. G.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>). <article-title>Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease</article-title>. <source/><italic toggle="yes">Neurology</italic>
<volume>56</volume>, <fpage>1059</fpage>-<lpage>1069</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.56.8.1059</pub-id><pub-id pub-id-type="pmid">11320179</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Côté</surname><given-names>P. D.</given-names></name>, <name name-style="western"><surname>Moukhles</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lindenbaum</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name></person-group> (<year>1999</year>). <article-title>Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses</article-title>. <source/><italic toggle="yes">Nat. Genet.</italic>
<volume>23</volume>, <fpage>338</fpage>-<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1038/15519</pub-id><pub-id pub-id-type="pmid">10610181</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>DeChiara</surname><given-names>T. M.</given-names></name>, <name name-style="western"><surname>Bowen</surname><given-names>D. C.</given-names></name>, <name name-style="western"><surname>Valenzuela</surname><given-names>D. M.</given-names></name>, <name name-style="western"><surname>Simmons</surname><given-names>M. V.</given-names></name>, <name name-style="western"><surname>Poueymirou</surname><given-names>W. T.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kinetz</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Compton</surname><given-names>D. L.</given-names></name>, <name name-style="western"><surname>Rojas</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>J. S.</given-names></name><etal>et al.</etal></person-group> (<year>1996</year>). <article-title>The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo</article-title>. <source/><italic toggle="yes">Cell</italic>
<volume>85</volume>, <fpage>501</fpage>-<lpage>512</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81251-9</pub-id><pub-id pub-id-type="pmid">8653786</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Deng</surname><given-names>W.-M.</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Frock</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Castillejo-Lopez</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Gaman</surname><given-names>E. A.</given-names></name>, <name name-style="western"><surname>Baumgartner</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Ruohola-Baker</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>130</volume>, <fpage>173</fpage>-<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1242/dev.00199</pub-id><pub-id pub-id-type="pmid">12441301</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Di Rosa</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Messina</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>D'Amico</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bertini</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Pustorino</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Spanò</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Tortorella</surname><given-names>G.</given-names></name></person-group> (<year>2011</year>). <article-title>A new form of alpha-dystroglycanopathy associated with severe drug-resistant epilepsy and unusual EEG features</article-title>. <source/><italic toggle="yes">Epileptic Disord.</italic>
<volume>13</volume>, <fpage>259</fpage>-<lpage>262</lpage>. <pub-id pub-id-type="doi">10.1684/epd.2011.0461</pub-id><pub-id pub-id-type="pmid">21914590</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Durbeej</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Ferletta</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name> and <name name-style="western"><surname>Ekblom</surname><given-names>P.</given-names></name></person-group> (<year>1998</year>). <article-title>Distribution of dystroglycan in normal adult mouse tissues</article-title>. <source/><italic toggle="yes">J. Histochem. Cytochem.</italic>
<volume>46</volume>, <fpage>449</fpage>-<lpage>457</lpage>. <pub-id pub-id-type="doi">10.1177/002215549804600404</pub-id><pub-id pub-id-type="pmid">9524190</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engel</surname><given-names>A. K.</given-names></name>, <name name-style="western"><surname>Fries</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Singer</surname><given-names>W.</given-names></name></person-group> (<year>2001</year>). <article-title>Dynamic predictions: oscillations and synchrony in top–down processing</article-title>. <source/><italic toggle="yes">Nat. Rev. Neurosci.</italic>
<volume>2</volume>, <fpage>704</fpage>-<lpage>716</lpage>. <pub-id pub-id-type="doi">10.1038/35094565</pub-id><pub-id pub-id-type="pmid">11584308</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eyermann</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Czaplinski</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Colognato</surname><given-names>H.</given-names></name></person-group> (<year>2012</year>). <article-title>Dystroglycan promotes filopodial formation and process branching in differentiating oligodendroglia</article-title>. <source/><italic toggle="yes">J. Neurochem.</italic>
<volume>120</volume>, <fpage>928</fpage>-<lpage>947</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2011.07600.x</pub-id><pub-id pub-id-type="pmid">22117643</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ferreira</surname><given-names>A.</given-names></name></person-group> (<year>1999</year>). <article-title>Abnormal synapse formation in agrin-depleted hippocampal neurons</article-title>. <source/><italic toggle="yes">J. Cell Sci.</italic>
<volume>112</volume>, <fpage>4729</fpage>-<lpage>4738</lpage>.<pub-id pub-id-type="pmid">10574720</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fort</surname><given-names>P. E.</given-names></name>, <name name-style="western"><surname>Sene</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pannicke</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Forster</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Mornet</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Nudel</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Yaffe</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Reichenbach</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sahel</surname><given-names>J. A.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Kir4.1 and AQP4 associate with Dp71- and utrophin-DAPs complexes in specific and defined microdomains of Müller retinal glial cell membrane</article-title>. <source/><italic toggle="yes">Glia</italic>
<volume>56</volume>, <fpage>597</fpage>-<lpage>610</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20633</pub-id><pub-id pub-id-type="pmid">18286645</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fruh</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Romanos</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Panzanelli</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Burgisser</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Tyagarajan</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name>, <name name-style="western"><surname>Santello</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Fritschy</surname><given-names>J.-M.</given-names></name></person-group> (<year>2016</year>). <article-title>Neuronal dystroglycan is necessary for formation and maintenance of functional CCK-positive basket cell terminals on pyramidal cells</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>36</volume>, <fpage>10296</fpage>-<lpage>10313</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1823-16.2016</pub-id><pub-id pub-id-type="pmid">27707967</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galvin</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Eyermann</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Colognato</surname><given-names>H.</given-names></name></person-group> (<year>2010</year>). <article-title>Dystroglycan modulates the ability of insulin-like growth factor-1 to promote oligodendrocyte differentiation</article-title>. <source/><italic toggle="yes">J. Neurosci. Res.</italic>
<volume>88</volume>, <fpage>3295</fpage>-<lpage>3307</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.22484</pub-id><pub-id pub-id-type="pmid">20857503</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gee</surname><given-names>S. H.</given-names></name>, <name name-style="western"><surname>Montanaro</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Lindenbaum</surname><given-names>M. H.</given-names></name> and <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name></person-group> (<year>1994</year>). <article-title>Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor</article-title>. <source/><italic toggle="yes">Cell</italic>
<volume>77</volume>, <fpage>675</fpage>-<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(94)90052-3</pub-id><pub-id pub-id-type="pmid">8205617</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geis</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Marquard</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Rödl</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Reihle</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Schirmer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kalle</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Bornemann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hehr</surname><given-names>U.</given-names></name> and <name name-style="western"><surname>Blankenburg</surname><given-names>M.</given-names></name></person-group> (<year>2013</year>). <article-title>Homozygous dystroglycan mutation associated with a novel muscle–eye–brain disease-like phenotype with multicystic leucodystrophy</article-title>. <source/><italic toggle="yes">Neurogenetics</italic>
<volume>14</volume>, <fpage>205</fpage>-<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1007/s10048-013-0374-9</pub-id><pub-id pub-id-type="pmid">24052401</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Geranmayeh</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Clement</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>L. H.</given-names></name>, <name name-style="western"><surname>Sewry</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pagan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Mein</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Abbs</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Brueton</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Childs</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Jungbluth</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations</article-title>. <source/><italic toggle="yes">Neuromuscul. Disord.</italic>
<volume>20</volume>, <fpage>241</fpage>-<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2010.02.001</pub-id><pub-id pub-id-type="pmid">20207543</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gerin</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ury</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Breloy</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Bouchet-Seraphin</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bolsée</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Halbout</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Graff</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Vertommen</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Muccioli</surname><given-names>G. G.</given-names></name>, <name name-style="western"><surname>Seta</surname><given-names>N.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto α-dystroglycan</article-title>. <source/><italic toggle="yes">Nat. Commun.</italic>
<volume>7</volume>, <fpage>11534</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms11534</pub-id><pub-id pub-id-type="pmid">27194101</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gesemann</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Brancaccio</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Schumacher</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Ruegg</surname><given-names>M. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Agrin is a high-affinity binding protein of dystroglycan in non-muscle tissue</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>273</volume>, <fpage>600</fpage>-<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.1.600</pub-id><pub-id pub-id-type="pmid">9417121</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glass</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Bowen</surname><given-names>D. C.</given-names></name>, <name name-style="western"><surname>Stitt</surname><given-names>T. N.</given-names></name>, <name name-style="western"><surname>Radziejewski</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ryan</surname><given-names>T. E.</given-names></name>, <name name-style="western"><surname>Gies</surname><given-names>D. R.</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mattsson</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Burden</surname><given-names>S. J.</given-names></name><etal>et al.</etal></person-group> (<year>1996</year>). <article-title>Agrin acts via a MuSK receptor complex</article-title>. <source/><italic toggle="yes">Cell</italic>
<volume>85</volume>, <fpage>513</fpage>-<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81252-0</pub-id><pub-id pub-id-type="pmid">8653787</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goddeeris</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Venzke</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Yoshida-Moriguchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Matsumura</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>2013</year>). <article-title>LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy</article-title>. <source/><italic toggle="yes">Nature</italic>
<volume>503</volume>, <fpage>136</fpage>-<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1038/nature12605</pub-id><pub-id pub-id-type="pmid">24132234</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godfrey</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Clement</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mein</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Brockington</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Talim</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Straub</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Robb</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Quinlivan</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group> (<year>2007</year>). <article-title>Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan</article-title>. <source/><italic toggle="yes">Brain</italic>
<volume>130</volume>, <fpage>2725</fpage>-<lpage>2735</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awm212</pub-id><pub-id pub-id-type="pmid">17878207</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Godfrey</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Foley</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Clement</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Muntoni</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>Dystroglycanopathies: coming into focus</article-title>. <source/><italic toggle="yes">Curr. Opin. Genet. Dev.</italic>
<volume>21</volume>, <fpage>278</fpage>-<lpage>285</lpage>. <pub-id pub-id-type="doi">10.1016/j.gde.2011.02.001</pub-id><pub-id pub-id-type="pmid">21397493</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gondo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Shinotsuka</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Morita</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Abe</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yasui</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Nuriya</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>Sustained down-regulation of β-dystroglycan and associated dysfunctions of astrocytic endfeet in epileptic cerebral cortex</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>289</volume>, <fpage>30279</fpage>-<lpage>30288</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M114.588384</pub-id><pub-id pub-id-type="pmid">25228692</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Górecki</surname><given-names>D. C.</given-names></name>, <name name-style="western"><surname>Derry</surname><given-names>J. M. J.</given-names></name> and <name name-style="western"><surname>Barnard</surname><given-names>E. A.</given-names></name></person-group> (<year>1994</year>). <article-title>Dystroglycan: brain localisation and chromosome mapping in the mouse</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>3</volume>, <fpage>1589</fpage>-<lpage>1597</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/3.9.1589</pub-id><pub-id pub-id-type="pmid">7833916</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gracida-Jiménez</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Mondragón-González</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Vélez-Aguilera</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Vásquez-Limeta</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Laredo-Cisneros</surname><given-names>M. S.</given-names></name>, <name name-style="western"><surname>Gómez-López</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Vaca</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Gourlay</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>L. A.</given-names></name>, <name name-style="western"><surname>Winder</surname><given-names>S. J.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>). <article-title>Retrograde trafficking of β-dystroglycan from the plasma membrane to the nucleus</article-title>. <source/><italic toggle="yes">Sci. Rep.</italic>
<volume>7</volume>, <fpage>9906</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-017-09972-x</pub-id><pub-id pub-id-type="pmid">28852008</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graus-Porta</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Blaess</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Senften</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Littlewood-Evans</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Damsky</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Orban</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Klein</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Schittny</surname><given-names>J. C.</given-names></name> and <name name-style="western"><surname>Müller</surname><given-names>U.</given-names></name></person-group> (<year>2001</year>). <article-title>β1-Class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>31</volume>, <fpage>367</fpage>-<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(01)00374-9</pub-id><pub-id pub-id-type="pmid">11516395</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graziano</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Messina</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Pegoraro</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Magri</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Prevalence of congenital muscular dystrophy in Italy: a population study</article-title>. <source/><italic toggle="yes">Neurology</italic>
<volume>84</volume>, <fpage>904</fpage>-<lpage>911</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000001303</pub-id><pub-id pub-id-type="pmid">25653289</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Grewal</surname><given-names>P. K.</given-names></name>, <name name-style="western"><surname>Holzfeind</surname><given-names>P. J.</given-names></name>, <name name-style="western"><surname>Bittner</surname><given-names>R. E.</given-names></name> and <name name-style="western"><surname>Hewitt</surname><given-names>J. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Mutant glycosyltransferase and altered glycosylation of alpha-dystroglycan in the myodystrophy mouse</article-title>. <source/><italic toggle="yes">Nat. Genet.</italic>
<volume>28</volume>, <fpage>151</fpage>-<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1038/88865</pub-id><pub-id pub-id-type="pmid">11381262</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guadagno</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Moukhles</surname><given-names>H.</given-names></name></person-group> (<year>2004</year>). <article-title>Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes</article-title>. <source/><italic toggle="yes">Glia</italic>
<volume>47</volume>, <fpage>138</fpage>-<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20039</pub-id><pub-id pub-id-type="pmid">15185393</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gumerson</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>C. S.</given-names></name>, <name name-style="western"><surname>Kabaeva</surname><given-names>Z. T.</given-names></name>, <name name-style="western"><surname>Hayes</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Brooks</surname><given-names>S. V.</given-names></name> and <name name-style="western"><surname>Michele</surname><given-names>D. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGEmyd mice</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>22</volume>, <fpage>757</fpage>-<lpage>768</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/dds483</pub-id><pub-id pub-id-type="pmid">23222475</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Kawahara</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gundry</surname><given-names>S. R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>A. T.</given-names></name>, <name name-style="western"><surname>Lencer</surname><given-names>W. I.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zon</surname><given-names>L. I.</given-names></name>, <name name-style="western"><surname>Kunkel</surname><given-names>L. M.</given-names></name> and <name name-style="western"><surname>Beggs</surname><given-names>A. H.</given-names></name></person-group> (<year>2011</year>). <article-title>The zebrafish dag1 mutant: a novel genetic model for dystroglycanopathies</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>20</volume>, <fpage>1712</fpage>-<lpage>1725</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr047</pub-id><pub-id pub-id-type="pmid">21296866</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Halfter</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Dong</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yip</surname><given-names>Y.-P.</given-names></name>, <name name-style="western"><surname>Willem</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Mayer</surname><given-names>U.</given-names></name></person-group> (<year>2002</year>). <article-title>A critical function of the pial basement membrane in cortical histogenesis</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>22</volume>, <fpage>6029</fpage>-<lpage>6040</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-14-06029.2002</pub-id><pub-id pub-id-type="pmid">12122064</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yoshida-Moriguchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Rader</surname><given-names>E. P.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Michele</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Muirhead</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Kunz</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Iannaccone</surname><given-names>S. T.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Basal lamina strengthens cell membrane integrity via the laminin G domain-binding motif of α-dystroglycan</article-title>. <source/><italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic>
<volume>106</volume>, <fpage>12573</fpage>-<lpage>12579</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0906545106</pub-id><pub-id pub-id-type="pmid">19633189</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hara</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Balci-Hayta</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Yoshida-Moriguchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Beltran-Valero de Bernabe</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Gündeşli</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Willer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Satz</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Crawford</surname><given-names>R. W.</given-names></name>, <name name-style="western"><surname>Burden</surname><given-names>S. J.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>A dystroglycan mutation associated with limb-girdle muscular dystrophy</article-title>. <source/><italic toggle="yes">N. Engl. J. Med.</italic>
<volume>364</volume>, <fpage>939</fpage>-<lpage>946</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1006939</pub-id><pub-id pub-id-type="pmid">21388311</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Henry</surname><given-names>M. D.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>1998</year>). <article-title>A role for dystroglycan in basement membrane assembly</article-title>. <source/><italic toggle="yes">Cell</italic>
<volume>95</volume>, <fpage>859</fpage>-<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81708-0</pub-id><pub-id pub-id-type="pmid">9865703</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Herbst</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Iskratsch</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Unger</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Bittner</surname><given-names>R. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Aberrant development of neuromuscular junctions in glycosylation-defective LARGEmyd mice</article-title>. <source/><italic toggle="yes">Neuromuscul. Disord.</italic>
<volume>19</volume>, <fpage>366</fpage>-<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2009.02.011</pub-id><pub-id pub-id-type="pmid">19346129</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hidalgo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sirour</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bello</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Moreau</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Beaudry</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Darribère</surname><given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>In vivo analyzes of dystroglycan function during somitogenesis in Xenopus laevis</article-title>. <source/><italic toggle="yes">Dev. Dyn.</italic>
<volume>238</volume>, <fpage>1332</fpage>-<lpage>1345</lpage>. <pub-id pub-id-type="doi">10.1002/dvdy.21814</pub-id><pub-id pub-id-type="pmid">19086027</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hildyard</surname><given-names>J. C. W.</given-names></name>, <name name-style="western"><surname>Lacey</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Booler</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hopkinson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>D. J.</given-names></name> and <name name-style="western"><surname>Brown</surname><given-names>S. C.</given-names></name></person-group> (<year>2016</year>). <article-title>Transgenic rescue of the LARGEmyd mouse: a large therapeutic window?</article-title>
<source/><italic toggle="yes">PLoS ONE</italic>
<volume>11</volume>, <fpage>e0159853</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0159853</pub-id><pub-id pub-id-type="pmid">27467128</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holt</surname><given-names>K. H.</given-names></name>, <name name-style="western"><surname>Crosbie</surname><given-names>R. H.</given-names></name>, <name name-style="western"><surname>Venzke</surname><given-names>D. P.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>2000</year>). <article-title>Biosynthesis of dystroglycan: processing of a precursor propeptide</article-title>. <source/><italic toggle="yes">FEBS Lett.</italic>
<volume>468</volume>, <fpage>79</fpage>-<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-5793(00)01195-9</pub-id><pub-id pub-id-type="pmid">10683445</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holzfeind</surname><given-names>P. J.</given-names></name>, <name name-style="western"><surname>Grewal</surname><given-names>P. K.</given-names></name>, <name name-style="western"><surname>Reitsamer</surname><given-names>H. A.</given-names></name>, <name name-style="western"><surname>Kechvar</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lassmann</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hoeger</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hewitt</surname><given-names>J. E.</given-names></name> and <name name-style="western"><surname>Bittner</surname><given-names>R. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Skeletal, cardiac and tongue muscle pathology, defective retinal transmission, and neuronal migration defects in the Large myd mouse defines a natural model for glycosylation-deficient muscle–eye–brain disorders</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>11</volume>, <fpage>2673</fpage>-<lpage>2687</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/11.21.2673</pub-id><pub-id pub-id-type="pmid">12354792</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Eade</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Breaches of the pial basement membrane and disappearance of the glia limitans during development underlie the cortical lamination defect in the mouse model of muscle-eye-brain disease</article-title>. <source/><italic toggle="yes">J. Comp. Neurol.</italic>
<volume>502</volume>, <fpage>168</fpage>-<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1002/cne.21238</pub-id><pub-id pub-id-type="pmid">17479518</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Candiello</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ball</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Cameron</surname><given-names>D. A.</given-names></name> and <name name-style="western"><surname>Halfter</surname><given-names>W.</given-names></name></person-group> (<year>2010</year>). <article-title>Retinal ectopias and mechanically weakened basement membrane in a mouse model of muscle-eye-brain (MEB) disease congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Mol. Vis.</italic>
<volume>16</volume>, <fpage>1415</fpage>-<lpage>1428</lpage>.<pub-id pub-id-type="pmid">20680099</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gagen</surname><given-names>C. S.</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>N. W.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name></person-group> (<year>2011a</year>). <article-title>Conditional knockout of protein O-mannosyltransferase 2 reveals tissue-specific roles of O-mannosyl glycosylation in brain development</article-title>. <source/><italic toggle="yes">J. Comp. Neurol.</italic>
<volume>519</volume>, <fpage>1320</fpage>-<lpage>1337</lpage>. <pub-id pub-id-type="doi">10.1002/cne.22572</pub-id><pub-id pub-id-type="pmid">21452199</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name> and <name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name></person-group> (<year>2011b</year>). <article-title>Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression</article-title>. <source/><italic toggle="yes">Neurosci. Lett.</italic>
<volume>489</volume>, <fpage>10</fpage>-<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2010.11.056</pub-id><pub-id pub-id-type="pmid">21129441</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Bampoe</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Postnatal gene therapy improves spatial learning despite the presence of neuronal ectopia in a model of neuronal migration disorder</article-title>. <source/><italic toggle="yes">Genes</italic>
<volume>7</volume>, <fpage>105</fpage>
<pub-id pub-id-type="doi">10.3390/genes7120105</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibraghimov-Beskrovnaya</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Ervasti</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Leveille</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>Slaughter</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Sernett</surname><given-names>S. W.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>1992</year>). <article-title>Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix</article-title>. <source/><italic toggle="yes">Nature</italic>
<volume>355</volume>, <fpage>696</fpage>-<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1038/355696a0</pub-id><pub-id pub-id-type="pmid">1741056</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ibraghimov-Beskrovnaya</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Milatovich</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ozcelik</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Koepnick</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Francke</surname><given-names>U.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>1993</year>). <article-title>Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>2</volume>, <fpage>1651</fpage>-<lpage>1657</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/2.10.1651</pub-id><pub-id pub-id-type="pmid">8268918</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ichikawa-Tomikawa</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Douet</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Kamikubo</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sakurai</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kohsaka</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Chiba</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Laminin alpha 1 is essential for mouse cerebellar development</article-title>. <source/><italic toggle="yes">Matrix Biol.</italic>
<volume>31</volume>, <fpage>17</fpage>-<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2011.09.002</pub-id><pub-id pub-id-type="pmid">21983115</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobson</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Montanaro</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Lindenbaum</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Ferns</surname><given-names>M.</given-names></name></person-group> (<year>1998</year>). <article-title>alpha-Dystroglycan functions in acetylcholine receptor aggregation but is not a coreceptor for agrin-MuSK signaling</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>18</volume>, <fpage>6340</fpage>-<lpage>6348</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-16-06340.1998</pub-id><pub-id pub-id-type="pmid">9698325</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jacobson</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Côté</surname><given-names>P. D.</given-names></name>, <name name-style="western"><surname>Rossi</surname><given-names>S. G.</given-names></name>, <name name-style="western"><surname>Rotundo</surname><given-names>R. L.</given-names></name> and <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name></person-group> (<year>2001</year>). <article-title>The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane</article-title>. <source/><italic toggle="yes">J. Cell Biol.</italic>
<volume>152</volume>, <fpage>435</fpage>-<lpage>450</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.152.3.435</pub-id><pub-id pub-id-type="pmid">11157973</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jae</surname><given-names>L. T.</given-names></name>, <name name-style="western"><surname>Raaben</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Riemersma</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van Beusekom</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Blomen</surname><given-names>V. A.</given-names></name>, <name name-style="western"><surname>Velds</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kerkhoven</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Carette</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Topaloglu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Meinecke</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry</article-title>. <source/><italic toggle="yes">Science</italic>
<volume>340</volume>, <fpage>479</fpage>-<lpage>483</lpage>. <pub-id pub-id-type="doi">10.1126/science.1233675</pub-id><pub-id pub-id-type="pmid">23519211</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jayasinha</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>H. H.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kammesheidt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hoyte</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Martin</surname><given-names>P. T.</given-names></name></person-group> (<year>2003</year>). <article-title>Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice</article-title>. <source/><italic toggle="yes">Neuromuscul. Disord.</italic>
<volume>13</volume>, <fpage>365</fpage>-<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-8966(03)00040-3</pub-id><pub-id pub-id-type="pmid">12798792</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jimenez-Mallebrera</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Torelli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Godfrey</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Clement</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mein</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Abbs</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>A comparative study of alpha-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha-dystroglycan does not consistently correlate with clinical severity</article-title>. <source/><italic toggle="yes">Brain Pathol.</italic>
<volume>19</volume>, <fpage>596</fpage>-<lpage>611</lpage>. <pub-id pub-id-type="doi">10.1111/j.1750-3639.2008.00198.x</pub-id><pub-id pub-id-type="pmid">18691338</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnson</surname><given-names>R. P.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>S. H.</given-names></name> and <name name-style="western"><surname>Kramer</surname><given-names>J. M.</given-names></name></person-group> (<year>2006</year>). <article-title>C. elegans dystroglycan DGN-1 functions in epithelia and neurons, but not muscle, and independently of dystrophin</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>133</volume>, <fpage>1911</fpage>-<lpage>1921</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02363</pub-id><pub-id pub-id-type="pmid">16611689</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Kunz</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yoshida-Moriguchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Barresi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>Y. M.</given-names></name>, <name name-style="western"><surname>Muschler</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Dumanski</surname><given-names>J. P.</given-names></name>, <name name-style="western"><surname>Michele</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Oldstone</surname><given-names>M. B. A.</given-names></name><etal>et al.</etal></person-group> (<year>2004</year>). <article-title>Molecular recognition by large is essential for expression of functional dystroglycan</article-title>. <source/><italic toggle="yes">Cell</italic>
<volume>117</volume>, <fpage>953</fpage>-<lpage>964</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2004.06.003</pub-id><pub-id pub-id-type="pmid">15210115</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Omori</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sato</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Miyagoe-Suzuki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Endo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Furukawa</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Post-translational maturation of dystroglycan is necessary for pikachurin binding and ribbon synaptic localization</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>285</volume>, <fpage>31208</fpage>-<lpage>31216</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.116343</pub-id><pub-id pub-id-type="pmid">20682766</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Tajiri</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Manya</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kuga</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Yamaguchi</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy</article-title>. <source/><italic toggle="yes">Cell Rep.</italic>
<volume>14</volume>, <fpage>2209</fpage>-<lpage>2223</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2016.02.017</pub-id><pub-id pub-id-type="pmid">26923585</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kawahara</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Guyon</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Kunkel</surname><given-names>L. M.</given-names></name></person-group> (<year>2009</year>). <article-title>Zebrafish models for human FKRP muscular dystrophies</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>19</volume>, <fpage>623</fpage>-<lpage>633</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp528</pub-id><pub-id pub-id-type="pmid">19955119</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Muscular dystrophy with ribitol-phosphate deficiency: a novel post-translational mechanism in dystroglycanopathy</article-title>. <source/><italic toggle="yes">J. Neuromuscul. Dis.</italic>
<volume>4</volume>, <fpage>259</fpage>-<lpage>267</lpage>. <pub-id pub-id-type="doi">10.3233/JND-170255</pub-id><pub-id pub-id-type="pmid">29081423</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Popko</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Francke</surname><given-names>U.</given-names></name></person-group> (<year>1994</year>). <article-title>Autosomal recessive neuromuscular disorder in a transgenic line of mice</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>14</volume>, <fpage>198</fpage>-<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.14-01-00198.1994</pub-id><pub-id pub-id-type="pmid">7506762</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Nakahori</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Miyake</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Matsumura</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kondo-Iida</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Nomura</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Segawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yoshioka</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Osawa</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>1998</year>). <article-title>An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Nature</italic>
<volume>394</volume>, <fpage>388</fpage>-<lpage>392</lpage>. <pub-id pub-id-type="doi">10.1038/28653</pub-id><pub-id pub-id-type="pmid">9690476</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurahashi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Taniguchi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Meno</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Taniguchi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Horie</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Otani</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name></person-group> (<year>2005</year>). <article-title>Basement membrane fragility underlies embryonic lethality in fukutin-null mice</article-title>. <source/><italic toggle="yes">Neurobiol. Dis.</italic>
<volume>19</volume>, <fpage>208</fpage>-<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2004.12.018</pub-id><pub-id pub-id-type="pmid">15837576</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larsen</surname><given-names>I. S. B.</given-names></name>, <name name-style="western"><surname>Narimatsu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>H. J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>O. J.</given-names></name>, <name name-style="western"><surname>Brasch</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Shapiro</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Honig</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Vakhrushev</surname><given-names>S. Y.</given-names></name>, <name name-style="western"><surname>Clausen</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2017</year>). <article-title>Mammalian O-mannosylation of cadherins and plexins is independent of Protein O-mannosyltransferase 1 and 2</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>292</volume>, <fpage>11586</fpage>-<lpage>11598</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M117.794487</pub-id><pub-id pub-id-type="pmid">28512129</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Larson</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Ii</surname><given-names>P. R. B.</given-names></name>, <name name-style="western"><surname>Milev</surname><given-names>M. P.</given-names></name>, <name name-style="western"><surname>Press</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Sokol</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>M. O.</given-names></name>, <name name-style="western"><surname>Lekostaj</surname><given-names>J. K.</given-names></name>, <name name-style="western"><surname>Stence</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Bossler</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Mueller</surname><given-names>J. M.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>). <article-title>TRAPPC11 and GOSR2 mutations associate with hypoglycosylation of α -dystroglycan and muscular dystrophy</article-title>. <source/><italic toggle="yes">Skelet. Muscle</italic>
<volume>8</volume>, <fpage>17</fpage>
<pub-id pub-id-type="doi">10.1186/s13395-018-0163-0</pub-id><pub-id pub-id-type="pmid">29855340</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kameya</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Cox</surname><given-names>G. A.</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hicks</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Maddatu</surname><given-names>T. P.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Naggert</surname><given-names>J. K.</given-names></name>, <name name-style="western"><surname>Peachey</surname><given-names>N. S.</given-names></name> and <name name-style="western"><surname>Nishina</surname><given-names>P. M.</given-names></name></person-group> (<year>2005</year>). <article-title>Ocular abnormalities in Large myd and Large vls mice, spontaneous models for muscle, eye, and brain diseases</article-title>. <source/><italic toggle="yes">Mol. Cell. Neurosci.</italic>
<volume>30</volume>, <fpage>160</fpage>-<lpage>172</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2005.07.009</pub-id><pub-id pub-id-type="pmid">16111892</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lefeber</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Schönberger</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Morava</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Guillard</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Huyben</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Verrijp</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Grafakou</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Evangeliou</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Preijers</surname><given-names>F. W.</given-names></name>, <name name-style="western"><surname>Manta</surname><given-names>P.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Deficiency of Dol-P-man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies</article-title>. <source/><italic toggle="yes">Am. J. Hum. Genet.</italic>
<volume>85</volume>, <fpage>76</fpage>-<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2009.06.006</pub-id><pub-id pub-id-type="pmid">19576565</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lefeber</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>de Brouwer</surname><given-names>A. P. M.</given-names></name>, <name name-style="western"><surname>Morava</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Riemersma</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Schuurs-Hoeijmakers</surname><given-names>J. H. M.</given-names></name>, <name name-style="western"><surname>Absmanner</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Verrijp</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>van den Akker</surname><given-names>W. M. R.</given-names></name>, <name name-style="western"><surname>Huijben</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Steenbergen</surname><given-names>G.</given-names></name><etal>et al.</etal></person-group> (<year>2011</year>). <article-title>Autosomal recessive dilated cardiomyopathy due to DOLK mutations results from abnormal dystroglycan o-mannosylation</article-title>. <source/><italic toggle="yes">PLoS Genet.</italic>
<volume>7</volume>, <fpage>e1002427</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1002427</pub-id><pub-id pub-id-type="pmid">22242004</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leschziner</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Moukhles</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lindenbaum</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gee</surname><given-names>S. H.</given-names></name>, <name name-style="western"><surname>Butterworth</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name> and <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name></person-group> (<year>2000</year>). <article-title>Neural regulation of α-dystroglycan biosynthesis and glycosylation in skeletal muscle</article-title>. <source/><italic toggle="yes">J. Neurochem.</italic>
<volume>74</volume>, <fpage>70</fpage>-<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2000.0740070.x</pub-id><pub-id pub-id-type="pmid">10617107</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Levedakou</surname><given-names>E. N.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X. J.</given-names></name>, <name name-style="western"><surname>Soliven</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Popko</surname><given-names>B.</given-names></name></person-group> (<year>2005</year>). <article-title>Disruption of the mouse Large gene in the enr and myd mutants results in nerve, muscle, and neuromuscular junction defects</article-title>. <source/><italic toggle="yes">Mol. Cell. Neurosci.</italic>
<volume>28</volume>, <fpage>757</fpage>-<lpage>769</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2004.12.007</pub-id><pub-id pub-id-type="pmid">15797722</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lévi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Grady</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name>, <name name-style="western"><surname>Sanes</surname><given-names>J. R.</given-names></name> and <name name-style="western"><surname>Craig</surname><given-names>A. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>22</volume>, <fpage>4274</fpage>-<lpage>4285</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.22-11-04274.2002</pub-id><pub-id pub-id-type="pmid">12040032</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Fässler</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Smyth</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Edgar</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Yurchenco</surname><given-names>P. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation</article-title>. <source/><italic toggle="yes">J. Cell Biol.</italic>
<volume>157</volume>, <fpage>1279</fpage>-<lpage>1290</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200203073</pub-id><pub-id pub-id-type="pmid">12082085</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Liquari</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>McKee</surname><given-names>K. K.</given-names></name>, <name name-style="western"><surname>Harrison</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Yurchenco</surname><given-names>P. D.</given-names></name></person-group> (<year>2005</year>). <article-title>Laminin-sulfatide binding initiates basement membrane assembly and enables receptor signaling in Schwann cells and fibroblasts</article-title>. <source/><italic toggle="yes">J. Cell Biol.</italic>
<volume>169</volume>, <fpage>179</fpage>-<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200501098</pub-id><pub-id pub-id-type="pmid">15824137</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Koirala</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hynes</surname><given-names>R. O.</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Corfas</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Piao</surname><given-names>X.</given-names></name></person-group> (<year>2008</year>). <article-title>GPR56 regulates pial basement membrane integrity and cortical lamination</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>28</volume>, <fpage>5817</fpage>-<lpage>5826</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0853-08.2008</pub-id><pub-id pub-id-type="pmid">18509043</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name></person-group> (<year>2011</year>). <article-title>Breaches of the pial basement membrane are associated with defective dentate gyrus development in mouse models of congenital muscular dystrophies</article-title>. <source/><italic toggle="yes">Neurosci. Lett.</italic>
<volume>505</volume>, <fpage>19</fpage>-<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2011.09.040</pub-id><pub-id pub-id-type="pmid">21970971</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>McKee</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>J.</given-names></name> and <name name-style="western"><surname>Yurchenco</surname><given-names>P. D.</given-names></name></person-group> (<year>2017</year>). <article-title>Integrin and dystroglycan compensate each other to mediate laminin-dependent basement membrane assembly and epiblast polarization</article-title>. <source/><italic toggle="yes">Matrix Biol.</italic>
<volume>57</volume>, <fpage>272</fpage>-<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2016.07.005</pub-id><pub-id pub-id-type="pmid">27449702</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hippenmeyer</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Ghashghaei</surname><given-names>H. T.</given-names></name></person-group> (<year>2012</year>). <article-title>A Nestin-cre transgenic mouse is insufficient for recombination in early embryonic neural progenitors</article-title>. <source/><italic toggle="yes">Biol. Open</italic>
<volume>1</volume>, <fpage>1200</fpage>-<lpage>1203</lpage>. <pub-id pub-id-type="doi">10.1242/bio.20122287</pub-id><pub-id pub-id-type="pmid">23259054</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>Y.-Y.</given-names></name>, <name name-style="western"><surname>White</surname><given-names>R. J.</given-names></name>, <name name-style="western"><surname>Torelli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Cirak</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Muntoni</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Stemple</surname><given-names>D. L.</given-names></name></person-group> (<year>2011</year>). <article-title>Zebrafish fukutin family proteins link the unfolded protein response with dystroglycanopathies</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>20</volume>, <fpage>1763</fpage>-<lpage>1775</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddr059</pub-id><pub-id pub-id-type="pmid">21317159</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ball</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Mei</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kaminski</surname><given-names>H. J.</given-names></name>, <name name-style="western"><surname>Lemmon</surname><given-names>V. P.</given-names></name> and <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1)</article-title>. <source/><italic toggle="yes">Mech. Dev.</italic>
<volume>123</volume>, <fpage>228</fpage>-<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/j.mod.2005.12.003</pub-id><pub-id pub-id-type="pmid">16458488</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lommel</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Winterhalter</surname><given-names>P. R.</given-names></name>, <name name-style="western"><surname>Willer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Dahlhoff</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Bartels</surname><given-names>M. F.</given-names></name>, <name name-style="western"><surname>Renner-Müller</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ruppert</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Wolf</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Strahl</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Protein O-mannosylation is crucial for E-cadherin–mediated cell adhesion</article-title>. <source/><italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic>
<volume>110</volume>, <fpage>21024</fpage>-<lpage>21029</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1316753110</pub-id><pub-id pub-id-type="pmid">24297939</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Longman</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Brockington</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Torelli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Jimenez-Mallebrera</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kennedy</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Khalil</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Saran</surname><given-names>R. K.</given-names></name>, <name name-style="western"><surname>Voit</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Merlini</surname><given-names>L.</given-names></name><etal>et al.</etal></person-group> (<year>2003</year>). <article-title>Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of α-dystroglycan</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>12</volume>, <fpage>2853</fpage>-<lpage>2861</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddg307</pub-id><pub-id pub-id-type="pmid">12966029</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lunardi</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Cremisi</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Dente</surname><given-names>L.</given-names></name></person-group> (<year>2006</year>). <article-title>Dystroglycan is required for proper retinal layering</article-title>. <source/><italic toggle="yes">Dev. Biol.</italic>
<volume>290</volume>, <fpage>411</fpage>-<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2005.11.044</pub-id><pub-id pub-id-type="pmid">16406325</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Luo</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Jeong</surname><given-names>S.-J.</given-names></name>, <name name-style="western"><surname>Jin</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Strokes</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Piao</surname><given-names>X.</given-names></name></person-group> (<year>2011</year>). <article-title>G protein-coupled receptor 56 and collagen III, a receptor-ligand pair, regulates cortical development and lamination</article-title>. <source/><italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic>
<volume>108</volume>, <fpage>12925</fpage>-<lpage>12930</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1104821108</pub-id><pub-id pub-id-type="pmid">21768377</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Manzini</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Tambunan</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Hill</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>T. W.</given-names></name>, <name name-style="western"><surname>Maynard</surname><given-names>T. M.</given-names></name>, <name name-style="western"><surname>Heinzen</surname><given-names>E. L.</given-names></name>, <name name-style="western"><surname>Shianna</surname><given-names>K. V.</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>C. R.</given-names></name>, <name name-style="western"><surname>Partlow</surname><given-names>J. N.</given-names></name>, <name name-style="western"><surname>Barry</surname><given-names>B. J.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of walker-warburg syndrome</article-title>. <source/><italic toggle="yes">Am. J. Hum. Genet.</italic>
<volume>91</volume>, <fpage>541</fpage>-<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.07.009</pub-id><pub-id pub-id-type="pmid">22958903</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrone</surname><given-names>A. K.</given-names></name>, <name name-style="western"><surname>Kucherenko</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Rishko</surname><given-names>V. M.</given-names></name> and <name name-style="western"><surname>Shcherbata</surname><given-names>H. R.</given-names></name></person-group> (<year>2011a</year>). <article-title>New Dystrophin/Dystroglycan interactors control neuron behavior in Drosophila eye</article-title>. <source/><italic toggle="yes">BMC Neurosci.</italic>
<volume>12</volume>, <fpage>93</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2202-12-93</pub-id><pub-id pub-id-type="pmid">21943192</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Marrone</surname><given-names>A. K.</given-names></name>, <name name-style="western"><surname>Kucherenko</surname><given-names>M. M.</given-names></name>, <name name-style="western"><surname>Wiek</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gopfert</surname><given-names>M. C.</given-names></name> and <name name-style="western"><surname>Shcherbata</surname><given-names>H. R.</given-names></name></person-group> (<year>2011b</year>). <article-title>Hyperthermic seizures and aberrant cellular homeostasis in Drosophila dystrophic muscles</article-title>. <source/><italic toggle="yes">Sci. Rep.</italic>
<volume>1</volume>, <fpage>47</fpage>
<pub-id pub-id-type="doi">10.1038/srep00047</pub-id><pub-id pub-id-type="pmid">22355566</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Martínez-Vieyra</surname><given-names>I. A.</given-names></name>, <name name-style="western"><surname>Vásquez-Limeta</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>González-Ramírez</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Morales-Lázaro</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Mondragón</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mondragón</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ortega</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Winder</surname><given-names>S. J.</given-names></name> and <name name-style="western"><surname>Cisneros</surname><given-names>B.</given-names></name></person-group> (<year>2013</year>). <article-title>A role for β-dystroglycan in the organization and structure of the nucleus in myoblasts</article-title>. <source/><italic toggle="yes">Biochim. Biophys. Acta</italic>
<volume>1833</volume>, <fpage>698</fpage>-<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2012.11.019</pub-id><pub-id pub-id-type="pmid">23220011</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masaki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Matsumura</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Sunada</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yorifuji</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Motoyoshi</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Kamakura</surname><given-names>K.</given-names></name></person-group> (<year>2000</year>). <article-title>Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration</article-title>. <source/><italic toggle="yes">Acta Neuropathol.</italic>
<volume>99</volume>, <fpage>289</fpage>-<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1007/PL00007440</pub-id><pub-id pub-id-type="pmid">10663972</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Masuda-Hirata</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Amano</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ide</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yamanaka</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sakai</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Imamura</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Ohno</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Intracellular polarity protein PAR-1 regulates extracellular laminin assembly by regulating the dystroglycan complex</article-title>. <source/><italic toggle="yes">Genes Cells</italic>
<volume>14</volume>, <fpage>835</fpage>-<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2443.2009.01315.x</pub-id><pub-id pub-id-type="pmid">19549170</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mathew</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mitchell</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Down</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Jacobs</surname><given-names>L. A.</given-names></name>, <name name-style="western"><surname>Hamdy</surname><given-names>F. C.</given-names></name>, <name name-style="western"><surname>Eaton</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Rosario</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Cross</surname><given-names>S. S.</given-names></name> and <name name-style="western"><surname>Winder</surname><given-names>S. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer</article-title>. <source/><italic toggle="yes">Sci. Rep.</italic>
<volume>3</volume>, <fpage>2792</fpage>
<pub-id pub-id-type="doi">10.1038/srep02792</pub-id><pub-id pub-id-type="pmid">24077328</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McClenahan</surname><given-names>F. K.</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Shan</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Eyermann</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Colognato</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Dystroglycan suppresses notch to regulate stem cell niche structure and function in the developing postnatal subventricular zone</article-title>. <source/><italic toggle="yes">Dev. Cell</italic>
<volume>38</volume>, <fpage>548</fpage>-<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2016.07.017</pub-id><pub-id pub-id-type="pmid">27569418</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McLone</surname><given-names>D. G.</given-names></name></person-group> (<year>1980</year>). <article-title>Development of the limiting glial membrane of the brain</article-title>. <source/><italic toggle="yes">Childs. Brain</italic>
<volume>6</volume>, <fpage>150</fpage>-<lpage>162</lpage>.<pub-id pub-id-type="pmid">7363728</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meilleur</surname><given-names>K. G.</given-names></name>, <name name-style="western"><surname>Zukosky</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Medne</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Fequiere</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Powell-Hamilton</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Winder</surname><given-names>T. L.</given-names></name>, <name name-style="western"><surname>Alsaman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>El-Hattab</surname><given-names>A. W.</given-names></name>, <name name-style="western"><surname>Dastgir</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hu</surname><given-names>Y.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Clinical, pathologic, and mutational spectrum of dystroglycanopathy caused by LARGE mutations</article-title>. <source/><italic toggle="yes">J. Neuropathol. Exp. Neurol.</italic>
<volume>73</volume>, <fpage>425</fpage>-<lpage>441</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0000000000000065</pub-id><pub-id pub-id-type="pmid">24709677</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mercuri</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Messina</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Mora</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pegoraro</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Comi</surname><given-names>G. P.</given-names></name>, <name name-style="western"><surname>D'Amico</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Aiello</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Biancheri</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Berardinelli</surname><given-names>A.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study</article-title>. <source/><italic toggle="yes">Neurology</italic>
<volume>72</volume>, <fpage>1802</fpage>-<lpage>1809</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000346518.68110.60</pub-id><pub-id pub-id-type="pmid">19299310</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Messina</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Tortorella</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Concolino</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Spano</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>D'Amico</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bruno</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Santorelli</surname><given-names>F. M.</given-names></name>, <name name-style="western"><surname>Mercuri</surname><given-names>E.</given-names></name> and <name name-style="western"><surname>Bertini</surname><given-names>E.</given-names></name></person-group> (<year>2009</year>). <article-title>Congenital muscular dystrophy with defective alpha-dystroglycan, cerebellar hypoplasia, and epilepsy</article-title>. <source/><italic toggle="yes">Neurology</italic>
<volume>73</volume>, <fpage>1599</fpage>-<lpage>1601</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181c0d47a</pub-id><pub-id pub-id-type="pmid">19901254</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Michele</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Barresi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Cohn</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Satz</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Dollar</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Nishino</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kelley</surname><given-names>R. I.</given-names></name>, <name name-style="western"><surname>Somer</surname><given-names>H.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>). <article-title>Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies</article-title>. <source/><italic toggle="yes">Nature</italic>
<volume>418</volume>, <fpage>417</fpage>-<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1038/nature00837</pub-id><pub-id pub-id-type="pmid">12140558</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Montanaro</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name> and <name name-style="western"><surname>Lindenbaum</surname><given-names>M.</given-names></name></person-group> (<year>1995</year>). <article-title>Dystroglycan expression in the wild type and mdx mouse neural retina: Synaptic colocalization with dystrophin, dystrophin-related protein but not laminin</article-title>. <source/><italic toggle="yes">J. Neurosci. Res.</italic>
<volume>42</volume>, <fpage>528</fpage>-<lpage>538</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.490420411</pub-id><pub-id pub-id-type="pmid">8568939</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>C. J.</given-names></name> and <name name-style="western"><surname>Winder</surname><given-names>S. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Dystroglycan versatility in cell adhesion: a tale of multiple motifs</article-title>. <source/><italic toggle="yes">Cell Commun. Signal.</italic>
<volume>8</volume>, <fpage>3</fpage>
<pub-id pub-id-type="doi">10.1186/1478-811X-8-3</pub-id><pub-id pub-id-type="pmid">20163697</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Michele</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Messing</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Cohn</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Ross-Barta</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Williamson</surname><given-names>R. A.</given-names></name><etal>et al.</etal></person-group> (<year>2002</year>). <article-title>Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Nature</italic>
<volume>418</volume>, <fpage>422</fpage>-<lpage>425</lpage>. <pub-id pub-id-type="doi">10.1038/nature00838</pub-id><pub-id pub-id-type="pmid">12140559</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Myshrall</surname><given-names>T. D.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Ostendorf</surname><given-names>A. P.</given-names></name>, <name name-style="western"><surname>Satz</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Kowalczyk</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Daza</surname><given-names>R. A. M.</given-names></name>, <name name-style="western"><surname>Lau</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name> and <name name-style="western"><surname>Hevner</surname><given-names>R. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Dystroglycan on radial glia endfeet is required for pial basement membrane integrity and columnar organization of the developing cerebral cortex</article-title>. <source/><italic toggle="yes">J. Neuropathol Exp Neurol</italic>
<volume>71</volume>, <fpage>1047</fpage>-<lpage>1063</lpage>. <pub-id pub-id-type="doi">10.1097/NEN.0b013e318274a128</pub-id><pub-id pub-id-type="pmid">23147502</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakagawa</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Yagi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Takematsu</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Oka</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Ectopic clustering of Cajal–Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy</article-title>. <source/><italic toggle="yes">Sci. Rep.</italic>
<volume>5</volume>, <fpage>11163</fpage>
<pub-id pub-id-type="doi">10.1038/srep11163</pub-id><pub-id pub-id-type="pmid">26060116</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakano</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Funahashi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Takada</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name></person-group> (<year>1996</year>). <article-title>Are breaches in the glia limitans the primary cause of the micropolygyria in Fukuyama-type congenital muscular dystrophy (FCMD)? - Pathological study of the cerebral cortex of an FCDM fetus</article-title>. <source/><italic toggle="yes">Acta Neuropathol.</italic>
<volume>91</volume>, <fpage>313</fpage>-<lpage>321</lpage>. <pub-id pub-id-type="doi">10.1007/s004010050431</pub-id><pub-id pub-id-type="pmid">8834545</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nakaya</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Sukowati</surname><given-names>E. W.</given-names></name> and <name name-style="western"><surname>Sheng</surname><given-names>G.</given-names></name></person-group> (<year>2013</year>). <article-title>Epiblast integrity requires CLASP and Dystroglycan-mediated microtubule anchoring to the basal cortex</article-title>. <source/><italic toggle="yes">J. Cell Biol.</italic>
<volume>202</volume>, <fpage>637</fpage>-<lpage>651</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201302075</pub-id><pub-id pub-id-type="pmid">23940118</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nguyen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ostendorf</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Satz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ross-Barta</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Moore</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Glial scaffold required for cerebellar granule cell migration is dependent on dystroglycan function as a receptor for basement membrane proteins</article-title>. <source/><italic toggle="yes">Acta Neuropathol. Commun.</italic>
<volume>1</volume>, <fpage>58</fpage>
<pub-id pub-id-type="doi">10.1186/2051-5960-1-58</pub-id><pub-id pub-id-type="pmid">24252195</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nodari</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Previtali</surname><given-names>S. C.</given-names></name>, <name name-style="western"><surname>Dati</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Occhi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Court</surname><given-names>F. A.</given-names></name>, <name name-style="western"><surname>Colombelli</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Zambroni</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Dina</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Del Carro</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>28</volume>, <fpage>6714</fpage>-<lpage>6719</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0326-08.2008</pub-id><pub-id pub-id-type="pmid">18579745</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noel</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Belda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Guadagno</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Micoud</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Klöcker</surname><given-names>N.</given-names></name> and <name name-style="western"><surname>Moukhles</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Dystroglycan and Kir4.1 coclustering in retinal Muller glia is regulated by laminin-1 and requires the PDZ-ligand domain of Kir4.1</article-title>. <source/><italic toggle="yes">J. Neurochem.</italic>
<volume>94</volume>, <fpage>691</fpage>-<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03191.x</pub-id><pub-id pub-id-type="pmid">16033419</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Noell</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wolburg-Buchholz</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mack</surname><given-names>A. F.</given-names></name>, <name name-style="western"><surname>Beedle</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Satz</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name>, <name name-style="western"><surname>Wolburg</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Fallier-Becker</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Evidence for a role of dystroglycan regulating the membrane architecture of astroglial endfeet</article-title>. <source/><italic toggle="yes">Eur. J. Neurosci.</italic>
<volume>33</volume>, <fpage>2179</fpage>-<lpage>2186</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2011.07688.x</pub-id><pub-id pub-id-type="pmid">21501259</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Miyata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nakajimat</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yagyu</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Seike</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ikenaka</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Mikoshibat</surname><given-names>K.</given-names></name></person-group> (<year>1995</year>). <article-title>The reeler gene-associated antigen on cajal-retzius neurons is a crucial molecule for laminar organization of cortical neurons</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>14</volume>, <fpage>899</fpage>-<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90329-1</pub-id><pub-id pub-id-type="pmid">7748558</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Omori</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Araki</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Chaya</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kajimura</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Irie</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Terada</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Muranishi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Tsujii</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ueno</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Koyasu</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Presynaptic dystroglycan-pikachurin complex regulates the proper synaptic connection between retinal photoreceptor and bipolar cells</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>32</volume>, <fpage>6126</fpage>-<lpage>6137</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0322-12.2012</pub-id><pub-id pub-id-type="pmid">22553019</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Orlandi</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Omori</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ueno</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Roux</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Condomitti</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>de Wit</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Furukawa</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2018</year>). <article-title>Transsynaptic binding of orphan receptor GPR179 to dystroglycan-pikachurin complex is essential for the synaptic organization of photoreceptors</article-title>. <source/><italic toggle="yes">Cell Rep.</italic>
<volume>25</volume>, <fpage>130</fpage>-<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2018.08.068</pub-id><pub-id pub-id-type="pmid">30282023</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmieri</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Manara</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Bello</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Mento</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lazzarini</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Borsato</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bortolussi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Angelini</surname><given-names>C.</given-names></name> and <name name-style="western"><surname>Pegoraro</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Cognitive profile and MRI findings in limb-girdle muscular dystrophy 2I</article-title>. <source/><italic toggle="yes">J. Neurol.</italic>
<volume>258</volume>, <fpage>1312</fpage>-<lpage>1320</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-011-5930-3</pub-id><pub-id pub-id-type="pmid">21293871</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Palmieri</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Bozzi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Signorino</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Papi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>De Spirito</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Brancaccio</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Maulucci</surname><given-names>G.</given-names></name> and <name name-style="western"><surname>Sciandra</surname><given-names>F.</given-names></name></person-group> (<year>2017</year>). <article-title>α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: a multiscale confocal microscopy analysis</article-title>. <source/><italic toggle="yes">BBA-Mol. Basis Dis.</italic>
<volume>1863</volume>, <fpage>2182</fpage>-<lpage>2191</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2017.05.025</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pane</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Messina</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vasco</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Foley</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Morandi</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Pegoraro</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mongini</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>D'Amico</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Bianco</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Lombardo</surname><given-names>M. E.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Respiratory and cardiac function in congenital muscular dystrophies with alpha dystroglycan deficiency</article-title>. <source/><italic toggle="yes">Neuromuscul. Disord.</italic>
<volume>22</volume>, <fpage>685</fpage>-<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1016/j.nmd.2012.05.006</pub-id><pub-id pub-id-type="pmid">22727687</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parames</surname><given-names>S. F.</given-names></name>, <name name-style="western"><surname>Coletta-Yudice</surname><given-names>E. D.</given-names></name>, <name name-style="western"><surname>Nogueira</surname><given-names>F. M.</given-names></name>, <name name-style="western"><surname>Nering de Sousa</surname><given-names>M. B.</given-names></name>, <name name-style="western"><surname>Hayashi</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Lima-Landman</surname><given-names>M. T. R.</given-names></name>, <name name-style="western"><surname>Lapa</surname><given-names>A. J.</given-names></name> and <name name-style="western"><surname>Souccar</surname><given-names>C.</given-names></name></person-group> (<year>2014</year>). <article-title>Altered acetylcholine release in the hippocampus of dystrophin-deficient mice</article-title>. <source/><italic toggle="yes">Neuroscience</italic>
<volume>269</volume>, <fpage>173</fpage>-<lpage>183</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.03.050</pub-id><pub-id pub-id-type="pmid">24704431</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parsons</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Campos</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Hirst</surname><given-names>E. M.</given-names></name> and <name name-style="western"><surname>Stemple</surname><given-names>D. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>129</volume>, <fpage>3505</fpage>-<lpage>3512</lpage>.<pub-id pub-id-type="pmid">12091319</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pawlisz</surname><given-names>A. S.</given-names></name> and <name name-style="western"><surname>Feng</surname><given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Three-dimensional regulation of radial glial functions by lis1-nde1 and dystrophin glycoprotein complexes</article-title>. <source/><italic toggle="yes">PLoS Biol.</italic>
<volume>9</volume>
<pub-id pub-id-type="doi">10.1371/journal.pbio.1001172</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>H. B.</given-names></name>, <name name-style="western"><surname>Ali</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Daggett</surname><given-names>D. F.</given-names></name>, <name name-style="western"><surname>Rauvala</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Hassell</surname><given-names>J. R.</given-names></name> and <name name-style="western"><surname>Smalheiser</surname><given-names>N. R.</given-names></name></person-group> (<year>1998</year>). <article-title>The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction</article-title>. <source/><italic toggle="yes">Cell Adhes. Commun.</italic>
<volume>5</volume>, <fpage>475</fpage>-<lpage>489</lpage>. <pub-id pub-id-type="doi">10.3109/15419069809005605</pub-id><pub-id pub-id-type="pmid">9791728</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peng</surname><given-names>H. B.</given-names></name>, <name name-style="western"><surname>Xie</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Rossi</surname><given-names>S. G.</given-names></name> and <name name-style="western"><surname>Rotundo</surname><given-names>R. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan</article-title>. <source/><italic toggle="yes">J. Cell Biol.</italic>
<volume>145</volume>, <fpage>911</fpage>-<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.145.4.911</pub-id><pub-id pub-id-type="pmid">10330416</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pihko</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lappi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Raitta</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sainio</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Valanne</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Somer</surname><given-names>H.</given-names></name> and <name name-style="western"><surname>Santavuori</surname><given-names>P.</given-names></name></person-group> (<year>1995</year>). <article-title>Ocular findings in muscle-eye-brain (MEB) disease: a follow-up study</article-title>. <source/><italic toggle="yes">Brain Dev.</italic>
<volume>17</volume>, <fpage>57</fpage>-<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/0387-7604(94)00101-3</pub-id><pub-id pub-id-type="pmid">7762765</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pöschl</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Schlötzer-Schrehardt</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Brachvogel</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Ninomiya</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Mayer</surname><given-names>U.</given-names></name></person-group> (<year>2004</year>). <article-title>Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>131</volume>, <fpage>1619</fpage>-<lpage>1628</lpage>. <pub-id pub-id-type="doi">10.1242/dev.01037</pub-id><pub-id pub-id-type="pmid">14998921</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pribiag</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Peng</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Shah</surname><given-names>W. A.</given-names></name>, <name name-style="western"><surname>Stellwagen</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses</article-title>. <source/><italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic>
<volume>111</volume>, <fpage>6810</fpage>-<lpage>6815</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1321774111</pub-id><pub-id pub-id-type="pmid">24753587</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qu</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Crandall</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Luo</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>McCaffery</surname><given-names>P. J.</given-names></name> and <name name-style="western"><surname>Smith</surname><given-names>F. I.</given-names></name></person-group> (<year>2006</year>). <article-title>Defects in tangential neuronal migration of pontine nuclei neurons in the Largemyd mouse are associated with stalled migration in the ventrolateral hindbrain</article-title>. <source/><italic toggle="yes">Eur. J. Neurosci.</italic>
<volume>23</volume>, <fpage>2877</fpage>-<lpage>2886</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04836.x</pub-id><pub-id pub-id-type="pmid">16819976</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radmanesh</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Caglayan</surname><given-names>A. O.</given-names></name>, <name name-style="western"><surname>Silhavy</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Yilmaz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Cantagrel</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Rosti</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kaymakcalan</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Gabriel</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities</article-title>. <source/><italic toggle="yes">Am. J. Hum. Genet.</italic>
<volume>92</volume>, <fpage>468</fpage>-<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.02.005</pub-id><pub-id pub-id-type="pmid">23472759</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Radner</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Banos</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bachay</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y. N.</given-names></name>, <name name-style="western"><surname>Hunter</surname><given-names>D. D.</given-names></name>, <name name-style="western"><surname>Brunken</surname><given-names>W. J.</given-names></name> and <name name-style="western"><surname>Yee</surname><given-names>K. T.</given-names></name></person-group> (<year>2013</year>). <article-title>β2 and γ3 laminins are critical cortical basement membrane components: Ablation of Lamb2 and Lamc3 genes disrupts cortical lamination and produces dysplasia</article-title>. <source/><italic toggle="yes">Dev. Neurobiol.</italic>
<volume>73</volume>, <fpage>209</fpage>-<lpage>229</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22057</pub-id><pub-id pub-id-type="pmid">22961762</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rae</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Scott</surname><given-names>R. B.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>C. H.</given-names></name>, <name name-style="western"><surname>Dixon</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Dumughn</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kemp</surname><given-names>G. J.</given-names></name>, <name name-style="western"><surname>Male</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Pike</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Styles</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Radda</surname><given-names>G. K.</given-names></name></person-group> (<year>1998</year>). <article-title>Brain biochemistry in Duchenne muscular dystrophy: A 1 H magnetic resonance and neuropsychological study</article-title>. <source/><italic toggle="yes">J. Neurol. Sci.</italic>
<volume>160</volume>, <fpage>148</fpage>-<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-510X(98)00190-7</pub-id><pub-id pub-id-type="pmid">9849797</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rae</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Griffin</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Blair</surname><given-names>D. H.</given-names></name>, <name name-style="western"><surname>Bothwell</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Bubb</surname><given-names>W. A.</given-names></name>, <name name-style="western"><surname>Maitland</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Head</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Abnormalities in brain biochemistry associated with lack of dystrophin: studies of the mdx mouse</article-title>. <source/><italic toggle="yes">Neuromuscul. Disord.</italic>
<volume>12</volume>, <fpage>121</fpage>-<lpage>129</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-8966(01)00253-X</pub-id><pub-id pub-id-type="pmid">11738353</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rambukkana</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zanazzi</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Mathus</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Salzer</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Yurchenco</surname><given-names>P. D.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name> and <name name-style="western"><surname>Fischetti</surname><given-names>V. A.</given-names></name></person-group> (<year>1998</year>). <article-title>Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae</article-title>. <source/><italic toggle="yes">Science</italic>
<volume>282</volume>, <fpage>2076</fpage>-<lpage>2079</lpage>. <pub-id pub-id-type="doi">10.1126/science.282.5396.2076</pub-id><pub-id pub-id-type="pmid">9851927</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rath</surname><given-names>E. M.</given-names></name>, <name name-style="western"><surname>Kelly</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Bouldin</surname><given-names>T. W.</given-names></name> and <name name-style="western"><surname>Popko</surname><given-names>B.</given-names></name></person-group> (<year>1995</year>). <article-title>Impaired peripheral nerve regeneration in a mutant strain of mice (Enr) with a Schwann cell defect</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>15</volume>, <fpage>7226</fpage>-<lpage>7237</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.15-11-07226.1995</pub-id><pub-id pub-id-type="pmid">7472477</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Riemersma</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Mandel</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>van Beusekom</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gazzoli</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Roscioli</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Eran</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gershoni-Baruch</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gershoni</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pietrokovski</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Vissers</surname><given-names>L.</given-names></name></person-group>, <etal>et al.</etal> (<year>2015</year>). <article-title>Absence of α- and β-dystroglycan is associated with Walker-Warburg syndrome</article-title>. <source/><italic toggle="yes">Neurology</italic>
<volume>84</volume>, <fpage>2177</fpage>-<lpage>2182</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000001615</pub-id><pub-id pub-id-type="pmid">25934851</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rodríguez Cruz</surname><given-names>P. M.</given-names></name>, <name name-style="western"><surname>Belaya</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Basiri</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sedghi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Farrugia</surname><given-names>M. E.</given-names></name>, <name name-style="western"><surname>Holton</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>W. W.</given-names></name>, <name name-style="western"><surname>Maxwell</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Petty</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Walls</surname><given-names>T. J.</given-names></name><etal>et al.</etal></person-group> (<year>2016</year>). <article-title>Clinical features of the myasthenic syndrome arising from mutations in GMPPB</article-title>. <source/><italic toggle="yes">J. Neurol. Neurosurg. Psychiatry</italic>
<volume>87</volume>, <fpage>802</fpage>-<lpage>809</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp-2016-313163</pub-id><pub-id pub-id-type="pmid">27147698</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roscioli</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kamsteeg</surname><given-names>E. J.</given-names></name>, <name name-style="western"><surname>Buysse</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Maystadt</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>van Reeuwijk</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>van den Elzen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>van Beusekom</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Riemersma</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pfundt</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Vissers</surname><given-names>L. E.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of alpha-dystroglycan</article-title>. <source/><italic toggle="yes">Nat. Genet.</italic>
<volume>44</volume>, <fpage>581</fpage>-<lpage>585</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2253</pub-id><pub-id pub-id-type="pmid">22522421</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rubio-Fernández</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Uribe</surname><given-names>M. L.</given-names></name>, <name name-style="western"><surname>Vicente-Tejedor</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Germain</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Susín-Lara</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Quereda</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Montoliu</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>De Villa</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Impairment of photoreceptor ribbon synapses in a novel Pomt1 conditional knockout mouse model of dystroglycanopathy</article-title>. <source/><italic toggle="yes">Sci. Rep.</italic>
<volume>8</volume>, <fpage>8543</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-26855-x</pub-id><pub-id pub-id-type="pmid">29867208</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rurak</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Noel</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Lui</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>B.</given-names></name> and <name name-style="western"><surname>Moukhles</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Distribution of potassium ion and water permeable channels at perivascular glia in brain and retina of the Largemyd mouse</article-title>. <source/><italic toggle="yes">J. Neurochem.</italic>
<volume>103</volume>, <fpage>1940</fpage>-<lpage>1953</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04886.x</pub-id><pub-id pub-id-type="pmid">17803675</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saito</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Murayama</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kawai</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Nakano</surname><given-names>I.</given-names></name></person-group> (<year>1999</year>). <article-title>Breached cerebral glia limitans-basal lamina complex in Fukuyama-type congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Acta Neuropathol.</italic>
<volume>98</volume>, <fpage>330</fpage>-<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1007/s004010051089</pub-id><pub-id pub-id-type="pmid">10502035</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Barresi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Messing</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ross-Barta</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Cohn</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Williamson</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Sluka</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Sherman</surname><given-names>D. L.</given-names></name><etal>et al.</etal></person-group> (<year>2003</year>). <article-title>Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>38</volume>, <fpage>747</fpage>-<lpage>758</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(03)00301-5</pub-id><pub-id pub-id-type="pmid">12797959</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Masaki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Nakamura</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Matsumura</surname><given-names>K.</given-names></name></person-group> (<year>2007</year>). <article-title>Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice</article-title>. <source/><italic toggle="yes">J. Neurochem.</italic>
<volume>101</volume>, <fpage>1712</fpage>-<lpage>1722</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2007.04462.x</pub-id><pub-id pub-id-type="pmid">17326765</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ikeda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hagiwara</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Masaki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ohkuma</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Katanosaka</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Sonoo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2014</year>). <article-title>Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>23</volume>, <fpage>4543</fpage>-<lpage>4558</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu168</pub-id><pub-id pub-id-type="pmid">24722207</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Santavuori</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Somer</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sainio</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Rapola</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kruus</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nikitin</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Ketonen</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Leisti</surname><given-names>J.</given-names></name></person-group> (<year>1989</year>). <article-title>Muscle-eye-brain disease (MEB)</article-title>. <source/><italic toggle="yes">Brain Dev.</italic>
<volume>11</volume>, <fpage>147</fpage>-<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/S0387-7604(89)80088-9</pub-id><pub-id pub-id-type="pmid">2751061</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Omori</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Katoh</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Miyata</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Funabiki</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Koyasu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kajimura</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Miyoshi</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2008</year>). <article-title>Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation</article-title>. <source/><italic toggle="yes">Nat. Neurosci.</italic>
<volume>11</volume>, <fpage>923</fpage>-<lpage>931</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2160</pub-id><pub-id pub-id-type="pmid">18641643</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satz</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Barresi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Durbeej</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Willer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>2008</year>). <article-title>Brain and eye malformations resembling Walker-Warburg syndrome are recapitulated in mice by dystroglycan deletion in the epiblast</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>28</volume>, <fpage>10567</fpage>-<lpage>10575</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2457-08.2008</pub-id><pub-id pub-id-type="pmid">18923033</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satz</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Philp</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kusano</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Turk</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Riker</surname><given-names>M. J.</given-names></name>, <name name-style="western"><surname>Hernandez</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Anderson</surname><given-names>M. G.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Visual impairment in the absence of dystroglycan</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>29</volume>, <fpage>13136</fpage>-<lpage>13146</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0474-09.2009</pub-id><pub-id pub-id-type="pmid">19846701</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Satz</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Ostendorf</surname><given-names>A. P.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kusano</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Turk</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ross-Barta</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2010</year>). <article-title>Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>30</volume>, <fpage>14560</fpage>-<lpage>14572</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3247-10.2010</pub-id><pub-id pub-id-type="pmid">20980614</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Khalil</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Poulton</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Castillejo-Lopez</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Egger-Adam</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Wodarz</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Deng</surname><given-names>W.-M.</given-names></name> and <name name-style="western"><surname>Baumgartner</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization</article-title>. <source/><italic toggle="yes">Development</italic>
<volume>133</volume>, <fpage>3805</fpage>-<lpage>3815</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02549</pub-id><pub-id pub-id-type="pmid">16943280</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schröder</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Tegeler</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Großhans</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Porten</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Blank</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Esapa</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Blake</surname><given-names>D. J.</given-names></name> and <name name-style="western"><surname>Kröger</surname><given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Dystroglycan regulates structure, proliferation and differentiation of neuroepithelial cells in the developing vertebrate CNS</article-title>. <source/><italic toggle="yes">Dev. Biol.</italic>
<volume>307</volume>, <fpage>62</fpage>-<lpage>78</lpage>. <pub-id pub-id-type="doi">10.1016/j.ydbio.2007.04.020</pub-id><pub-id pub-id-type="pmid">17512925</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sekine</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kawauchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kubo</surname><given-names>K. I.</given-names></name>, <name name-style="western"><surname>Honda</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Herz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kinashi</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Nakajima</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>Reelin controls neuronal positioning by promoting cell-matrix adhesion via inside-out activation of Integrin alpha5beta1</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>76</volume>, <fpage>353</fpage>-<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.07.020</pub-id><pub-id pub-id-type="pmid">23083738</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shcherbata</surname><given-names>H. R.</given-names></name>, <name name-style="western"><surname>Yatsenko</surname><given-names>A. S.</given-names></name>, <name name-style="western"><surname>Patterson</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sood</surname><given-names>V. D.</given-names></name>, <name name-style="western"><surname>Nudel</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Yaffe</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Baker</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Ruohola-Baker</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Dissecting muscle and neuronal disorders in a Drosophila model of muscular dystrophy</article-title>. <source/><italic toggle="yes">EMBO J.</italic>
<volume>26</volume>, <fpage>481</fpage>-<lpage>493</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601503</pub-id><pub-id pub-id-type="pmid">17215867</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sievers</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Doeberitz</surname><given-names>C. V. K.</given-names></name>, <name name-style="western"><surname>Pehlemann</surname><given-names>F.</given-names></name> and <name name-style="western"><surname>Berry</surname><given-names>M.</given-names></name></person-group> (<year>1986</year>). <article-title>Anatomy and Embryology Meningeal cells influence cerebellar development over a critical period</article-title>. <source/><italic toggle="yes">Anat. Embryol.</italic>
<volume>175</volume>, <fpage>91</fpage>-<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1007/BF00315459</pub-id><pub-id pub-id-type="pmid">3099597</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sievers</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pehlemann</surname><given-names>F. W.</given-names></name>, <name name-style="western"><surname>Gude</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Berry</surname><given-names>M.</given-names></name></person-group> (<year>1994</year>). <article-title>Meningeal cells organize the superficial glia limitans of the cerebellum and produce components of both the interstitial matrix and the basement membrane</article-title>. <source/><italic toggle="yes">J. Neurocytol.</italic>
<volume>23</volume>, <fpage>135</fpage>-<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1007/BF01183867</pub-id><pub-id pub-id-type="pmid">8195812</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Signorino</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Covaceuszach</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bozzi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hübner</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Mönkemöller</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Konarev</surname><given-names>P. V.</given-names></name>, <name name-style="western"><surname>Cassetta</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Brancaccio</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Sciandra</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein</article-title>. <source/><italic toggle="yes">Hum. Mutat.</italic>
<volume>39</volume>, <fpage>266</fpage>-<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23370</pub-id><pub-id pub-id-type="pmid">29134705</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sirour</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hidalgo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Bello</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Buisson</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Darribère</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Moreau</surname><given-names>N.</given-names></name></person-group> (<year>2011</year>). <article-title>Dystroglycan is involved in skin morphogenesis downstream of the Notch signaling pathway</article-title>. <source/><italic toggle="yes">Mol. Biol. Cell</italic>
<volume>22</volume>, <fpage>2957</fpage>-<lpage>2969</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e11-01-0074</pub-id><pub-id pub-id-type="pmid">21680717</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smalheiser</surname><given-names>N. R.</given-names></name> and <name name-style="western"><surname>Kim</surname><given-names>E.</given-names></name></person-group> (<year>1995</year>). <article-title>Purification of cranin, a laminin binding membrane protein. Identity with dystroglycan and reassessment of its carbohydrate moieties</article-title>. <source/><italic toggle="yes">J. Biol. Chem.</italic>
<volume>270</volume>, <fpage>15425</fpage>-<lpage>15433</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.270.25.15425</pub-id><pub-id pub-id-type="pmid">7797531</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stevens</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Carss</surname><given-names>K. J.</given-names></name>, <name name-style="western"><surname>Cirak</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Foley</surname><given-names>A. R.</given-names></name>, <name name-style="western"><surname>Torelli</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Willer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tambunan</surname><given-names>D. E.</given-names></name>, <name name-style="western"><surname>Yau</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Brodd</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sewry</surname><given-names>C. A.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan</article-title>. <source/><italic toggle="yes">Am. J. Hum. Genet.</italic>
<volume>92</volume>, <fpage>354</fpage>-<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2013.01.016</pub-id><pub-id pub-id-type="pmid">23453667</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Struckhoff</surname><given-names>G.</given-names></name></person-group> (<year>1995</year>). <article-title>Cocultures of meningeal and astrocytic cells-A model for the formation of the glial-limiting membrane</article-title>. <source/><italic toggle="yes">Int. J. Dev. Neurosci.</italic>
<volume>13</volume>, <fpage>595</fpage>-<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1016/0736-5748(95)00040-N</pub-id><pub-id pub-id-type="pmid">8553894</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sudo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kanagawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chiyomi</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Endo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Minami</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Aiba</surname><given-names>A.</given-names></name> and <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name></person-group> (<year>2018</year>). <article-title>Temporal requirement of dystroglycan glycosylation during brain development and rescue of severe cortical dysplasia via gene delivery in the fetal stage</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>27</volume>, <fpage>1174</fpage>-<lpage>1185</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddy032</pub-id><pub-id pub-id-type="pmid">29360985</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sugita</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Satz</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Sudhof</surname><given-names>T. C.</given-names></name></person-group> (<year>2001</year>). <article-title>A stoichiometric complex of neurexins and dystroglycan in brain</article-title>. <source/><italic toggle="yes">J. Cell Biol.</italic>
<volume>154</volume>, <fpage>435</fpage>-<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200105003</pub-id><pub-id pub-id-type="pmid">11470830</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sugiyama</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Bowen</surname><given-names>D. C.</given-names></name> and <name name-style="western"><surname>Hall</surname><given-names>Z. W.</given-names></name></person-group> (<year>1994</year>). <article-title>Dystroglycan binds nerve and muscle agrin</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>13</volume>, <fpage>103</fpage>-<lpage>115</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(94)90462-6</pub-id><pub-id pub-id-type="pmid">8043271</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takahashi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kanesaki</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Igarashi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kameya</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yamaki</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mizota</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kudo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Miyagoe-Suzuki</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Takahashi</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Reactive gliosis of astrocytes and Müller glial cells in retina of POMGnT1-deficient mice</article-title>. <source/><italic toggle="yes">Mol. Cell. Neurosci.</italic>
<volume>47</volume>, <fpage>119</fpage>-<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2011.03.006</pub-id><pub-id pub-id-type="pmid">21447391</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeda</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kurahashi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kano</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Arai</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Misaki</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Fukui</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Tachikawa</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2003</year>). <article-title>Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>12</volume>, <fpage>1449</fpage>-<lpage>1459</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddg153</pub-id><pub-id pub-id-type="pmid">12783852</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Takeuchi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Nakano</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>U.</given-names></name>, <name name-style="western"><surname>Kaneda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Aizu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Awano</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Yonemura</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kiyonaka</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mori</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>D.</given-names></name><etal>et al.</etal></person-group> (<year>2009</year>). <article-title>Changes in temperature preferences and energy homeostasis in dystroglycan mutants</article-title>. <source/><italic toggle="yes">Science</italic>
<volume>323</volume>, <fpage>1740</fpage>-<lpage>1743</lpage>. <pub-id pub-id-type="doi">10.1126/science.1165712</pub-id><pub-id pub-id-type="pmid">19325118</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamaru</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ban</surname><given-names>E. A.</given-names></name>, <name name-style="western"><surname>Manya</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Endo</surname><given-names>T.</given-names></name> and <name name-style="western"><surname>Akiyama</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Molecular characterization of protein O-linked mannose β-1,2-N-acetylglucosaminyltransferase 1 in Zebrafish</article-title>. <source/><italic toggle="yes">J. Glycomics Lipidomics</italic>
<volume>4</volume>, <fpage>111</fpage>
<pub-id pub-id-type="doi">10.4172/2153-0637.1000111</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Thornhill</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Bassett</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Lochmüller</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bushby</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Straub</surname><given-names>V.</given-names></name></person-group> (<year>2008</year>). <article-title>Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP)</article-title>. <source/><italic toggle="yes">Brain</italic>
<volume>131</volume>, <fpage>1551</fpage>-<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awn078</pub-id><pub-id pub-id-type="pmid">18477595</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Trkova</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Krutilkova</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Smetanova</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Becvarova</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Hlavova</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Jencikova</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Hodacova</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Hnykova</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hroncova</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Horacek</surname><given-names>J.</given-names></name><etal>et al.</etal></person-group> (<year>2015</year>). <article-title>ISPD gene homozygous deletion identified by SNP array confirms prenatal manifestation of Walker-Warburg syndrome</article-title>. <source/><italic toggle="yes">Eur. J. Med. Genet.</italic>
<volume>58</volume>, <fpage>372</fpage>-<lpage>375</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2015.05.004</pub-id><pub-id pub-id-type="pmid">26087224</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tukker</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Fuentealba</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Hartwich</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Somogyi</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Klausberger</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Cell type-specific tuning of hippocampal interneuronfiring during gamma oscillations</article-title>. <source/><italic toggle="yes">J. Neurosci.</italic>
<volume>27</volume>, <fpage>8184</fpage>-<lpage>8189</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1685-07.2007</pub-id><pub-id pub-id-type="pmid">17670965</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tuon</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Comim</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Fraga</surname><given-names>D. B.</given-names></name>, <name name-style="western"><surname>Scaini</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Rezin</surname><given-names>G. T.</given-names></name>, <name name-style="western"><surname>Baptista</surname><given-names>B. R.</given-names></name>, <name name-style="western"><surname>Streck</surname><given-names>E. L.</given-names></name>, <name name-style="western"><surname>Vainzof</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Quevedo</surname><given-names>J.</given-names></name></person-group> (<year>2010</year>). <article-title>Mitochondrial respiratory chain and creatine kinase activities in mdx mouse brain</article-title>. <source/><italic toggle="yes">Muscle Nerve</italic>
<volume>41</volume>, <fpage>257</fpage>-<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1002/mus.21559</pub-id><pub-id pub-id-type="pmid">20082314</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Uhlhaas</surname><given-names>P. J.</given-names></name> and <name name-style="western"><surname>Singer</surname><given-names>W.</given-names></name></person-group> (<year>2006</year>). <article-title>Neural synchrony in brain disorders: relevance for cognitive dysfunctions and pathophysiology</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>52</volume>, <fpage>155</fpage>-<lpage>168</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2006.09.020</pub-id><pub-id pub-id-type="pmid">17015233</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vajsar</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ackerley</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Chitayat</surname><given-names>D.</given-names></name> and <name name-style="western"><surname>Becker</surname><given-names>L. E.</given-names></name></person-group> (<year>2000</year>). <article-title>Basal lamina abnormality in the skeletal muscle of Walker-Warburg syndrome</article-title>. <source/><italic toggle="yes">Pediatr. Neurol.</italic>
<volume>22</volume>, <fpage>139</fpage>-<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/S0887-8994(99)00129-0</pub-id><pub-id pub-id-type="pmid">10738921</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vannoy</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Keramaris</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>X.</given-names></name> and <name name-style="western"><surname>Lu</surname><given-names>Q.</given-names></name></person-group> (<year>2014</year>). <article-title>AAV-mediated overexpression of LARGE rescues alpha-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein</article-title>. <source/><italic toggle="yes">Hum Gene Ther Methods</italic>
<volume>25</volume>, <fpage>187</fpage>-<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1089/hgtb.2013.151</pub-id><pub-id pub-id-type="pmid">24635668</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Reeuwijk</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Janssen</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>van den Elzen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Beltran-Valero de Bernabé</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Sabatelli</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Merlini</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Boon</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Scheffer</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Brockington</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Muntoni</surname><given-names>F.</given-names></name><etal>et al.</etal></person-group> (<year>2005</year>). <article-title>POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome</article-title>. <source/><italic toggle="yes">J. Med. Genet.</italic>
<volume>42</volume>, <fpage>907</fpage>-<lpage>912</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2005.031963</pub-id><pub-id pub-id-type="pmid">15894594</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vester-Christensen</surname><given-names>M. B.</given-names></name>, <name name-style="western"><surname>Halim</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Joshi</surname><given-names>H. J.</given-names></name>, <name name-style="western"><surname>Steentoft</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Bennett</surname><given-names>E. P.</given-names></name>, <name name-style="western"><surname>Levery</surname><given-names>S. B.</given-names></name>, <name name-style="western"><surname>Vakhrushev</surname><given-names>S. Y.</given-names></name> and <name name-style="western"><surname>Clausen</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins</article-title>. <source/><italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic>
<volume>110</volume>, <fpage>21018</fpage>-<lpage>21023</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1313446110</pub-id><pub-id pub-id-type="pmid">24101494</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vohra</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ghidini</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Alvarez</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Lockwood</surname><given-names>C.</given-names></name></person-group> (<year>1993</year>). <article-title>Walker-warburg syndrome: prenatal ultrasound findings</article-title>. <source/><italic toggle="yes">Prenat. Diagn.</italic>
<volume>13</volume>, <fpage>575</fpage>-<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1002/pd.1970130707</pub-id><pub-id pub-id-type="pmid">8415422</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>von Renesse</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Petkova</surname><given-names>M. V.</given-names></name>, <name name-style="western"><surname>Lützkendorf</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Heinemeyer</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Gill</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Hübner</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>von Moers</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Stenzel</surname><given-names>W.</given-names></name> and <name name-style="western"><surname>Schuelke</surname><given-names>M.</given-names></name></person-group> (<year>2014</year>). <article-title>POMK mutation in a family with congenital muscular dystrophy with merosin deficiency, hypomyelination, mild hearing deficit and intellectual disability</article-title>. <source/><italic toggle="yes">J. Med. Genet.</italic>
<volume>51</volume>, <fpage>275</fpage>-<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2013-102236</pub-id><pub-id pub-id-type="pmid">24556084</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vuillaumier-Barrot</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bouchet-Séraphin</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Chelbi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Devisme</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Quentin</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gazal</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Laquerrière</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Fallet-Bianco</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Loget</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Odent</surname><given-names>S.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly</article-title>. <source/><italic toggle="yes">Am. J. Hum. Genet.</italic>
<volume>91</volume>, <fpage>1135</fpage>-<lpage>1143</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2012.10.009</pub-id><pub-id pub-id-type="pmid">23217329</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Whitmore</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Fernandez-Fuente</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Booler</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Parr</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kavishwar</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ashraf</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lacey</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Terry</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ackroyd</surname><given-names>M. R.</given-names></name><etal>et al.</etal></person-group> (<year>2013</year>). <article-title>The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>23</volume>, <fpage>1842</fpage>-<lpage>1855</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddt577</pub-id><pub-id pub-id-type="pmid">24234655</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Prados</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Falcón-Pérez</surname><given-names>J. M.</given-names></name>, <name name-style="western"><surname>Renner-Müller</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Przemeck</surname><given-names>G. K. H.</given-names></name>, <name name-style="western"><surname>Lommel</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Coloma</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Valero</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>de Angelis</surname><given-names>M. H.</given-names></name>, <name name-style="western"><surname>Tanner</surname><given-names>W.</given-names></name><etal>et al.</etal></person-group> (<year>2004</year>). <article-title>Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality</article-title>. <source/><italic toggle="yes">Proc. Natl. Acad. Sci. USA</italic>
<volume>101</volume>, <fpage>14126</fpage>-<lpage>14131</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0405899101</pub-id><pub-id pub-id-type="pmid">15383666</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Willer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lommel</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yoshida-Moriguchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>de Bernabe</surname><given-names>D. B.</given-names></name>, <name name-style="western"><surname>Venzke</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Cirak</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schachter</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Vajsar</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Voit</surname><given-names>T.</given-names></name><etal>et al.</etal></person-group> (<year>2012</year>). <article-title>ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome</article-title>. <source/><italic toggle="yes">Nat. Genet.</italic>
<volume>44</volume>, <fpage>575</fpage>-<lpage>580</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2252</pub-id><pub-id pub-id-type="pmid">22522420</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Williamson</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Henry</surname><given-names>M. D.</given-names></name>, <name name-style="western"><surname>Daniels</surname><given-names>K. J.</given-names></name>, <name name-style="western"><surname>Hrstka</surname><given-names>R. F.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Sunada</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Ibraghimov-Beskrovnaya</surname><given-names>O.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>1997</year>). <article-title>Dystroglycan is essential for early embryonic development: disruption of Reichert's Membrane in dag1-null mice</article-title>. <source/><italic toggle="yes">Hum. Mol. Genet.</italic>
<volume>6</volume>, <fpage>831</fpage>-<lpage>841</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/6.6.831</pub-id><pub-id pub-id-type="pmid">9175728</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wright</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Lyon</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Leung</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Leahy</surname><given-names>D. J.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Ginty</surname><given-names>D. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Dystroglycan organizes axon guidance cue localization and axonal pathfinding</article-title>. <source/><italic toggle="yes">Neuron</italic>
<volume>76</volume>, <fpage>931</fpage>-<lpage>944</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.10.009</pub-id><pub-id pub-id-type="pmid">23217742</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xin</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Poy</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Joachimiak</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sudol</surname><given-names>M.</given-names></name> and <name name-style="western"><surname>Eck</surname><given-names>M. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan</article-title>. <source/><italic toggle="yes">Nat. Struct. Biol.</italic>
<volume>7</volume>, <fpage>634</fpage>-<lpage>638</lpage>. <pub-id pub-id-type="doi">10.1038/77923</pub-id><pub-id pub-id-type="pmid">10932245</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yagi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nakagawa</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kiyonari</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Abe</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>S.-W.</given-names></name>, <name name-style="western"><surname>Khoo</surname><given-names>K.-H.</given-names></name>, <name name-style="western"><surname>Oka</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Kato</surname><given-names>K.</given-names></name></person-group> (<year>2013</year>). <article-title>AGO61-dependent GlcNAc modification primes the formation of functional glycans on α-dystroglycan</article-title>. <source/><italic toggle="yes">Sci. Rep.</italic>
<volume>3</volume>, <fpage>3288</fpage>
<pub-id pub-id-type="doi">10.1038/srep03288</pub-id><pub-id pub-id-type="pmid">24256719</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamada</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Shimizu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name> and <name name-style="western"><surname>Matsumura</surname><given-names>K.</given-names></name></person-group> (<year>1994</year>). <article-title>Dystroglycan is a binding protein of laminin and merosin in peripheral nerve</article-title>. <source/><italic toggle="yes">FEBS Lett.</italic>
<volume>352</volume>, <fpage>49</fpage>-<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(94)00917-1</pub-id><pub-id pub-id-type="pmid">7925941</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Toyoda</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kondo</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Osawa</surname><given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Pial-glial barrier abnormalities in fetuses with Fukuyama congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Brain Dev.</italic>
<volume>19</volume>, <fpage>35</fpage>-<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/S0387-7604(96)00056-3</pub-id><pub-id pub-id-type="pmid">9071488</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamamoto</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kawaguchi-Niida</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Shibata</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Osawa</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kroger</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Kobayashi</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Characteristics of neurons and glia in the brain of Fukuyama type congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Acta Myol.</italic>
<volume>27</volume>, <fpage>9</fpage>-<lpage>13</lpage>.<pub-id pub-id-type="pmid">19108571</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Xiong</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Ectopia of Meningeal Fibroblasts and Reactive Gliosis in the cerebral cortex of the mouse model of muscle-eye-brain disease</article-title>. <source/><italic toggle="yes">J. Comp. Neurol.</italic>
<volume>504</volume>, <fpage>287</fpage>-<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1002/cne.21410</pub-id><pub-id pub-id-type="pmid">17640051</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>A. C.</given-names></name>, <name name-style="western"><surname>Ng</surname><given-names>B. G.</given-names></name>, <name name-style="western"><surname>Moore</surname><given-names>S. A.</given-names></name>, <name name-style="western"><surname>Rush</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Waechter</surname><given-names>C. J.</given-names></name>, <name name-style="western"><surname>Raymond</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Willer</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name>, <name name-style="western"><surname>Freeze</surname><given-names>H. H.</given-names></name> and <name name-style="western"><surname>Mehta</surname><given-names>L.</given-names></name></person-group> (<year>2013</year>). <article-title>Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Mol. Genet. Metab.</italic>
<volume>110</volume>, <fpage>345</fpage>-<lpage>351</lpage>. <pub-id pub-id-type="doi">10.1016/j.ymgme.2013.06.016</pub-id><pub-id pub-id-type="pmid">23856421</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Manya</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Taniguchi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kano</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Mizuno</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Inazu</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Mitsuhashi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Takahashi</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Takeuchi</surname><given-names>M.</given-names></name><etal>et al.</etal></person-group> (<year>2001</year>). <article-title>Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1</article-title>. <source/><italic toggle="yes">Dev. Cell</italic>
<volume>1</volume>, <fpage>717</fpage>-<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1016/S1534-5807(01)00070-3</pub-id><pub-id pub-id-type="pmid">11709191</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshida-Moriguchi</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Stalnaker</surname><given-names>S. H.</given-names></name>, <name name-style="western"><surname>Davis</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kunz</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Madson</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Oldstone</surname><given-names>M. B. A.</given-names></name>, <name name-style="western"><surname>Schachter</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Wells</surname><given-names>L.</given-names></name> and <name name-style="western"><surname>Campbell</surname><given-names>K. P.</given-names></name></person-group> (<year>2010</year>). <article-title>O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding</article-title>. <source/><italic toggle="yes">Science</italic>
<volume>327</volume>, <fpage>88</fpage>-<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1126/science.1180512</pub-id><pub-id pub-id-type="pmid">20044576</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yoshioka</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name> and <name name-style="western"><surname>Toda</surname><given-names>T.</given-names></name></person-group> (<year>2017</year>). <article-title>Novel FKRP mutations in a Japanese MDC1C sibship clinically diagnosed with Fukuyama congenital muscular dystrophy</article-title>. <source/><italic toggle="yes">Brain Dev.</italic>
<volume>39</volume>, <fpage>869</fpage>-<lpage>872</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2017.05.013</pub-id><pub-id pub-id-type="pmid">28629604</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>S.</given-names></name> and <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy</article-title>. <source/><italic toggle="yes">Hum. Gene Ther.</italic>
<volume>24</volume>, <fpage>317</fpage>-<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1089/hum.2012.084</pub-id><pub-id pub-id-type="pmid">23379513</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zaccaria</surname><given-names>M. L.</given-names></name>, <name name-style="western"><surname>Di Tommaso</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Brancaccio</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Paggi</surname><given-names>P.</given-names></name> and <name name-style="western"><surname>Petrucci</surname><given-names>T. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Dystroglycan distribution in adult mouse brain: a light and electron microscopy study</article-title>. <source/><italic toggle="yes">Neuroscience</italic>
<volume>104</volume>, <fpage>311</fpage>-<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(01)00092-6</pub-id><pub-id pub-id-type="pmid">11377836</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhan</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Melian</surname><given-names>N. Y.</given-names></name>, <name name-style="western"><surname>Pantoja</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Haines</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ruohola-Baker</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Bourque</surname><given-names>C. W.</given-names></name>, <name name-style="western"><surname>Rao</surname><given-names>Y.</given-names></name> and <name name-style="western"><surname>Carbonetto</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Dystroglycan and mitochondrial ribosomal protein L34 regulate differentiation in the Drosophila eye</article-title>. <source/><italic toggle="yes">PLoS ONE</italic>
<volume>5</volume>, <fpage>e10488</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0010488</pub-id><pub-id pub-id-type="pmid">20463973</pub-id></mixed-citation>
</ref>
<ref id="DMM035931C226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Candiello</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Thorn</surname><given-names>T. L.</given-names></name>, <name name-style="western"><surname>Gray</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Halfter</surname><given-names>W. M.</given-names></name> and <name name-style="western"><surname>Hu</surname><given-names>H.</given-names></name></person-group> (<year>2013</year>). <article-title>Biochemical and biophysical changes underlie the mechanisms of basement membrane disruptions in a mouse model of dystroglycanopathy</article-title>. <source/><italic toggle="yes">Matrix Biol.</italic>
<volume>32</volume>, <fpage>196</fpage>-<lpage>207</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2013.02.002</pub-id><pub-id pub-id-type="pmid">23454088</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>